<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">22206</article-id><article-id pub-id-type="doi">10.7554/eLife.22206</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-70705"><name><surname>Fielding</surname><given-names>Ceri A</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5817-3153</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-71775"><name><surname>Weekes</surname><given-names>Michael P</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3196-5545</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="equal-contrib">†</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="other" rid="data-ro1"/></contrib><contrib contrib-type="author" id="author-71776"><name><surname>Nobre</surname><given-names>Luis V</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0467-8989</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71777"><name><surname>Ruckova</surname><given-names>Eva</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71778"><name><surname>Wilkie</surname><given-names>Gavin S</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23686"><name><surname>Paulo</surname><given-names>Joao A</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4291-413X</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71779"><name><surname>Chang</surname><given-names>Chiwen</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81240"><name><surname>Suárez</surname><given-names>Nicolás M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8429-8374</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71781"><name><surname>Davies</surname><given-names>James A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-45164"><name><surname>Antrobus</surname><given-names>Robin</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8608-4011</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71782"><name><surname>Stanton</surname><given-names>Richard J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6799-1182</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71783"><name><surname>Aicheler</surname><given-names>Rebecca J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">§</xref></contrib><contrib contrib-type="author" id="author-71784"><name><surname>Nichols</surname><given-names>Hester</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6814-4364</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71785"><name><surname>Vojtesek</surname><given-names>Borek</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33933"><name><surname>Trowsdale</surname><given-names>John</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0150-5698</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-71786"><name><surname>Davison</surname><given-names>Andrew J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4991-9128</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13119"><name><surname>Gygi</surname><given-names>Steven P</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-71787"><name><surname>Tomasec</surname><given-names>Peter</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6745-6198</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib2">‡</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-57098"><name><surname>Lehner</surname><given-names>Paul J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9383-1054</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib2">‡</xref><xref ref-type="other" rid="par-9"/><xref ref-type="other" rid="par-10"/><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-70706"><name><surname>Wilkinson</surname><given-names>Gavin W G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5623-0126</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="equal-contrib2">‡</xref><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Division of Infection and Immunity, School of Medicine</institution>, <institution>Cardiff University</institution>, <addr-line><named-content content-type="city">Cardiff</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Cambridge Institute for Medical Research</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Cell Biology</institution>, <institution>Harvard Medical School</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Regional Centre for Applied Molecular Oncology</institution>, <institution>Masaryk Memorial Cancer Institute</institution>, <addr-line><named-content content-type="city">Brno</named-content></addr-line>, <country>Czech Republic</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">MRC-University of Glasgow Centre for Virus Research</institution>, <institution>University of Glasgow</institution>, <addr-line><named-content content-type="city">Glasgow</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Immunology Division, Department of Pathology</institution>, <institution>University of Cambridge</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yokoyama</surname><given-names>Wayne M</given-names></name><role>Reviewing editor</role><aff id="aff7"><institution>Howard Hughes Medical Institute, Washington University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><email>Wilkinsongw1@cardiff.ac.uk</email></corresp><fn fn-type="present-address" id="pa1"><label>§</label><p>Cardiff School of Health Sciences, Cardiff Metropolitan University, Cardiff, United Kingdom</p></fn><fn fn-type="con" id="equal-contrib"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="con" id="equal-contrib2"><label>‡</label><p>These authors also contributed equally to this work</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic"><day>10</day><month>02</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e22206</elocation-id><history><date date-type="received"><day>08</day><month>10</month><year>2016</year></date><date date-type="accepted"><day>09</day><month>02</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Fielding et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Fielding et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-22206-v3.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.22206.001</object-id><p>The human cytomegalovirus (HCMV) US12 family consists of ten sequentially arranged genes (US12-21) with poorly characterized function. We now identify novel natural killer (NK) cell evasion functions for four members: US12, US14, US18 and US20. Using a systematic multiplexed proteomics approach to quantify ~1300 cell surface and ~7200 whole cell proteins, we demonstrate that the US12 family selectively targets plasma membrane proteins and plays key roles in regulating NK ligands, adhesion molecules and cytokine receptors. US18 and US20 work in concert to suppress cell surface expression of the critical NKp30 ligand B7-H6 thus inhibiting NK cell activation. The US12 family is therefore identified as a major new hub of immune regulation.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.001">http://dx.doi.org/10.7554/eLife.22206.001</ext-link></p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.22206.002</object-id><title>eLife digest</title><p>Cytomegalovirus (CMV) is one of eight herpesviruses that can infect humans. Most people will at some point become infected with CMV, yet the virus tends only to cause serious disease in people whose immune system is not working properly. Individuals living with HIV/AIDS and organ transplant recipients (who have to take drugs that suppress their immune system to prevent the organ being rejected) are particularly vulnerable to CMV infections. Critically, the virus can cross the placenta to infect of the foetus. CMV infection in the womb can cause miscarriage, lead to severe developmental problems in babies and is a major cause of deafness.</p><p>Herpesvirus infections are for life. While the immune system cannot eliminate CMV, it does have many systems that combine to sense and control infections. Natural killer cells are known to play a critical role in detecting and destroying cells infected with CMV. The virus, in turn, has nine genes that help to protect it against natural killer cells. This includes two genes that belong to a group of similar genes called the US12 family, but it is not clear whether other members of this gene family also provide protection against natural killer cells.</p><p>Fielding <italic>et al.</italic> now show that at least four members of the US12 gene family help CMV to evade natural killer cells. For example, two members work together to target a human protein called B7-H6 that acts a sensor to alert natural killer cells if a particular cell is infected. However, the impact of the US12 family goes even wider. The whole family works together to control proteins that are found on the surface of human cells, and many of these proteins appear to be involved in regulating the immune response.</p><p>The findings of Fielding et al. provide an insight into how the US12 gene family works, and how CMV has evolved to escape the human immune system. New therapies to control CMV infections are urgently needed so the next challenge is to design new antiviral agents that will target CMV’s defence systems.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.002">http://dx.doi.org/10.7554/eLife.22206.002</ext-link></p></abstract><kwd-group kwd-group-type="author-keywords"><title>Author Keywords</title><kwd>cytomegalovirus</kwd><kwd>human</kwd><kwd>immune evasion</kwd><kwd>natural killer cell</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research Organism</title><kwd>Virus</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>108070/Z/15/Z</award-id><principal-award-recipient><name><surname>Weekes</surname><given-names>Michael P</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>K01 DK098285</award-id><principal-award-recipient><name><surname>Paulo</surname><given-names>Joao A</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001824</institution-id><institution>Czech Science Foundation</institution></institution-wrap></funding-source><award-id>P206/12/G151</award-id><principal-award-recipient><name><surname>Chang</surname><given-names>Chiwen</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>695551</award-id><principal-award-recipient><name><surname>Vojtesek</surname><given-names>Borek</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>G0901682</award-id><principal-award-recipient><name><surname>Trowsdale</surname><given-names>John</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MRC G1000236</award-id><principal-award-recipient><name><surname>Tomasec</surname><given-names>Peter</given-names></name><name><surname>Wilkinson</surname><given-names>Gavin W G</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT090323MA</award-id><principal-award-recipient><name><surname>Tomasec</surname><given-names>Peter</given-names></name><name><surname>Wilkinson</surname><given-names>Gavin W G</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/L018373/1</award-id><principal-award-recipient><name><surname>Tomasec</surname><given-names>Peter</given-names></name><name><surname>Wilkinson</surname><given-names>Gavin W G</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>Wellcome</institution></institution-wrap></funding-source><award-id>WT101835</award-id><principal-award-recipient><name><surname>Lehner</surname><given-names>Paul J</given-names></name></principal-award-recipient></award-group><award-group id="par-10"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome</institution></institution-wrap></funding-source><award-id>100140</award-id><principal-award-recipient><name><surname>Lehner</surname><given-names>Paul J</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>elife-xml-version</meta-name><meta-value>2.5</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The human cytomegalovirus US12 gene family work co-operatively to degrade large numbers of immune ligands and prevent recognition by natural killer cells.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>At 236 kb the human cytomegalovirus (HCMV) genome is the largest of any characterized human virus and is comprised of long and short unique regions (U<sub>L</sub> and U<sub>S</sub>), each flanked by inverted terminal repeats. HCMV codes for around of 170 canonical protein-coding genes with 39 herpesvirus ‘core’ genes concentrated in the center of the U<sub>L</sub> region (<xref ref-type="bibr" rid="bib16">Dolan et al., 2004</xref>). The core genes mainly encode structural components of the virion and proteins required for virus DNA replication and have orthologues in the other human herpesviruses. The vast majority of the remaining HCMV genes are not essential for virus replication <italic>in vitro</italic> (<xref ref-type="bibr" rid="bib17">Dunn et al., 2003</xref>) yet are replete with accessory functions, many of which have been implicated in suppressing host immune responses. Unusually, HCMV encodes 15 gene families of variable size that are often clustered on the genome (<xref ref-type="bibr" rid="bib12">Davison et al., 2002</xref>; <xref ref-type="bibr" rid="bib25">Holzerlandt et al., 2002</xref>; <xref ref-type="bibr" rid="bib5">Chee et al., 1990</xref>; <xref ref-type="bibr" rid="bib16">Dolan et al., 2004</xref>; <xref ref-type="bibr" rid="bib13">Davison et al., 2003</xref>). Many of these gene families exhibit homology with cellular genes and are conserved to various extents in other primate CMVs. Consequently, these primate CMV gene families are likely to have arisen through gene capture and amplification driven by differential selective pressures in their various primate hosts over millennia (<xref ref-type="bibr" rid="bib14">Davison et al., 2013</xref>, <xref ref-type="bibr" rid="bib13">2003</xref>).</p><p>The US12 gene family consists of 10 genes, designated US12 to US21, arranged sequentially in the U<sub>S</sub> region and transcribed in the same orientation (<xref ref-type="bibr" rid="bib5">Chee et al., 1990</xref>; <xref ref-type="bibr" rid="bib16">Dolan et al., 2004</xref>). The genetic arrangement of the US12 family is reminiscent of ‘accordion’ gene expansions, which are generated when a cellular or virus resistance function is placed under strong selective pressure (<xref ref-type="bibr" rid="bib20">Filée, 2013</xref>). Such an expansion was recently exemplified experimentally using a poxvirus interferon resistance function (<xref ref-type="bibr" rid="bib18">Elde et al., 2012</xref>). The US12 family encodes a series of 7-transmembrane spanning proteins with low-level homology to the cellular transmembrane bax-inhibitor one motif-containing proteins (TMBIM). While not essential for virus replication, the US12 family has been implicated in HCMV tropism, virion maturation and immune evasion (<xref ref-type="bibr" rid="bib11">Das and Pellett, 2007</xref>; <xref ref-type="bibr" rid="bib4">Cavaletto et al., 2015</xref>; <xref ref-type="bibr" rid="bib2">Bronzini et al., 2012</xref>; <xref ref-type="bibr" rid="bib22">Hai et al., 2006</xref>; <xref ref-type="bibr" rid="bib21">Gurczynski et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>).</p><p>Natural Killer (NK) cells play a critical role in controlling HCMV infections, and the virus invests a substantial proportion of its coding capacity to inhibit NK cell activation (<xref ref-type="bibr" rid="bib57">Wilkinson et al., 2013</xref>). We previously observed that US18 and US20 suppress cell surface expression of the NK cell-activating ligand MICA (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>) and posited that the synergistic action of US18 and US20 may be the vestige of an immune selective pressure that drove the original expansion of the US12 family. These data show that multiple US12 family members can co-operate to target the same cellular protein. Therefore individual functions, as identified with single gene viral mutants, may not be readily replicated by expressing these same viral genes in isolation, i.e. these viral genes may work more efficiently in the context of HCMV productive infection.</p><p>To investigate the function of <italic>all</italic> US12 family genes, we undertook a systematic functional analysis that showed four members were NK immunevasins. Conventional biochemical investigations on US12 family proteins are rendered problematic due to their extreme hydrophobicity. We therefore undertook multiplexed Tandem Mass Tag (TMT)-based proteomic analyses to systematically evaluate the capacity of all US12 family genes to modulate the cellular proteome, both individually and in concert. Such an approach has been enabled by our recent development of Plasma Membrane Profiling (PMP) to identify novel cell surface targets for the HCMV latency protein UL138 (<xref ref-type="bibr" rid="bib55">Weekes et al., 2013</xref>) and individual viral immunevasins UL141 and US2 (<xref ref-type="bibr" rid="bib26">Hsu et al., 2015</xref>). Quantitative Temporal Viromics (QTV) allowed &gt;8000 cellular and 153 viral proteins to be tracked throughout the course of productive HCMV infection, thus building a comprehensive picture of cellular control by the virus (<xref ref-type="bibr" rid="bib56">Weekes et al., 2014</xref>). Through comparative analysis of ~1300 cell surface and ~7200 cellular proteins during infection with HCMV US12 family deletion mutants, we now describe in detail how this family has a profound influence not only on NK cell recognition but other key functions that impact on immunity including cellular adhesion and cytokine signalling.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>US12 family members differentially affect NK cell activation</title><p>To determine whether the US12 family has a broader role in modulating NK cell responses, a series of HCMV US12 family deletion mutants were generated (10 single deletion mutants and the US12-21 ‘block’ deletion). The HCMV genome was manipulated by DNA recombineering in a strain Merlin BAC that did not express RL13 and UL128 (<xref ref-type="bibr" rid="bib47">Stanton et al., 2010</xref>). Viruses were generated by DNA transfection and the complete genomic sequence of the virus stocks was validated by deep sequencing (<xref ref-type="table" rid="tbl1">Table 1</xref>). In NK functional assays, the △US12-21 block deletion mutant induced substantially higher levels of NK cell degranulation compared to the parent HCMV with all four different donors tested (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Significantly increased levels of NK activation were detected in assays using deletion mutants of 5 different US12 family members: US12 (3 of 4 donors), US14 (1 of 4 donors, with a trend towards increased NK activation in the other three donors), US18 (3 of 4 donors), US20 (4 of 4 donors), US21 (4 of 4 donors) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), while three US12 family deletion mutants (US15, US16, US19) reduced the level of NK cell activation in some donors (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Although members of the US12 family are capable individually of either activating or suppressing NK cell function, the net effect of the complete US12 gene family is clearly to inhibit NK cell recognition.<fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.003</object-id><label>Figure 1.</label><caption><title>Multiple US12 family proteins regulate NK activation.</title><p>(<bold>A</bold>) Fibroblasts (HF-TERTs) were mock infected or infected with the Merlin strain of HCMV or the series of US12 family deletion mutants for 72 hr. Infected cells were incubated with donor PBMC for 5 hr and NK degranulation assessed by % CD107<sup>+</sup> cells within the CD3<sup>-</sup>, CD56<sup>+</sup> population by flow cytometry. (<bold>B</bold>) CD107 assay results (mean and SD) are shown from four separate donors performed in duplicate or triplicate and analysed by unpaired ordinary one way ANOVA with Dunnett’s test for multiple comparisons against the HCMV control *p&lt;0.05, **p&lt;0.01, ***p&lt;0.005 ***p&lt;0.001). Infected cells were assessed by the % cells with down-regulated MHC I compared to the mock-infected cells (for the experiment using donor #23 and # 385, HCMV 93%, ΔUS12 94%, ΔUS13 98%, ΔUS14 94%, ΔUS15 98%, ΔUS16 99%, ΔUS17 98%, ΔUS18 97%, ΔUS19 99%, ΔUS20 97%, ΔUS21 91%, ΔUS12-21 94%; for the experiment using donor #91 and # 285, HCMV 94%, ΔUS12 94%, ΔUS13 94%, ΔUS14 83%, ΔUS15 95%, ΔUS16 97%, ΔUS17 85%, ΔUS18 94%, ΔUS19 96%, ΔUS20 94%, ΔUS21 94%, ΔUS12-21 96%).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.003">http://dx.doi.org/10.7554/eLife.22206.003</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig1-v3"/></fig><table-wrap id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.004</object-id><label>Table 1.</label><caption><p>HCMV constructs used in the study.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.004">http://dx.doi.org/10.7554/eLife.22206.004</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"><bold>Virus</bold></th><th style="background: #fcfafa;" valign="top"><bold>BAC #</bold></th><th style="background: #fcfafa;" valign="top"><bold>Accession no.</bold></th><th style="background: #fcfafa;" valign="top"><bold>Cassette used</bold></th><th style="background: #fcfafa;" valign="top"><bold>Modification</bold></th><th style="background: #fcfafa;" valign="top"><bold>Previous reference</bold></th></tr></thead><tbody><tr><td style="background: #fcfafa;" valign="top">HCMV</td><td style="background: #fcfafa;" valign="top">1111</td><td style="background: #fcfafa;" valign="top">GU179001.1</td><td style="background: #fcfafa;" valign="top">None</td><td style="background: #fcfafa;" valign="top">RL13<sup>-</sup>, UL128<sup>-</sup></td><td style="background: #fcfafa;" valign="top"><xref ref-type="bibr" rid="bib47">Stanton et al. (2010)</xref></td></tr><tr><td style="background: #fcfafa;" valign="top">△US12</td><td style="background: #fcfafa;" valign="top">1810</td><td style="background: #fcfafa;" valign="top">KU221097</td><td style="background: #fcfafa;" valign="top">GalK</td><td style="background: #fcfafa;" valign="top">US12 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US13</td><td style="background: #fcfafa;" valign="top">1831</td><td style="background: #fcfafa;" valign="top">KU221099</td><td style="background: #fcfafa;" valign="top">GalK</td><td style="background: #fcfafa;" valign="top">US13 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US14</td><td style="background: #fcfafa;" valign="top">1798</td><td style="background: #fcfafa;" valign="top">KU221093</td><td style="background: #fcfafa;" valign="top">GalK</td><td style="background: #fcfafa;" valign="top">US14 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US15</td><td style="background: #fcfafa;" valign="top">1800</td><td style="background: #fcfafa;" valign="top">KU221094</td><td style="background: #fcfafa;" valign="top">GalK</td><td style="background: #fcfafa;" valign="top">US15 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US16</td><td style="background: #fcfafa;" valign="top">1802</td><td style="background: #fcfafa;" valign="top">KU221095</td><td style="background: #fcfafa;" valign="top">GalK</td><td style="background: #fcfafa;" valign="top">US16 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US17</td><td style="background: #fcfafa;" valign="top">1804</td><td style="background: #fcfafa;" valign="top">KU221096</td><td style="background: #fcfafa;" valign="top">GalK</td><td style="background: #fcfafa;" valign="top">US17 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US18</td><td style="background: #fcfafa;" valign="top">1654</td><td style="background: #fcfafa;" valign="top">KU221091</td><td style="background: #fcfafa;" valign="top">RpsL-Neo-LacZ</td><td style="background: #fcfafa;" valign="top">US18 CDS deleted</td><td style="background: #fcfafa;" valign="top"><xref ref-type="bibr" rid="bib19">Fielding et al. (2014)</xref></td></tr><tr><td style="background: #fcfafa;" valign="top">△US19</td><td style="background: #fcfafa;" valign="top">1796</td><td style="background: #fcfafa;" valign="top">KU221092</td><td style="background: #fcfafa;" valign="top">RpsL-Neo-LacZ</td><td style="background: #fcfafa;" valign="top">US19 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US20</td><td style="background: #fcfafa;" valign="top">1595</td><td style="background: #fcfafa;" valign="top">KU221090</td><td style="background: #fcfafa;" valign="top">SacB-AmpR-LacZ</td><td style="background: #fcfafa;" valign="top">US20 CDS deleted</td><td style="background: #fcfafa;" valign="top"><xref ref-type="bibr" rid="bib19">Fielding et al. (2014)</xref></td></tr><tr><td style="background: #fcfafa;" valign="top">△US21</td><td style="background: #fcfafa;" valign="top">1871</td><td style="background: #fcfafa;" valign="top">KU221100</td><td style="background: #fcfafa;" valign="top">RpsL-Neo-LacZ</td><td style="background: #fcfafa;" valign="top">US21 CDS deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr><tr><td style="background: #fcfafa;" valign="top">△US12-21</td><td style="background: #fcfafa;" valign="top">1815</td><td style="background: #fcfafa;" valign="top">KU221098</td><td style="background: #fcfafa;" valign="top">RpsL-Neo-LacZ</td><td style="background: #fcfafa;" valign="top">US12-21 deleted</td><td style="background: #fcfafa;" valign="top">None</td></tr></tbody></table></table-wrap></p></sec><sec id="s2-2"><title>The US12 family targets plasma membrane proteins</title><p>To provide an unbiased systematic analysis of the entire US12 gene family, we employed 10-plex tandem-mass tags (TMT) with MS3/Multinotch mass spectrometry to quantify whole cell (WCL) and plasma membrane (PM) proteomes in fibroblasts infected with the panel of HCMV US12 family mutants. The proteomic analyses were performed in two parts to permit inclusion of appropriate controls. Samples analyzed in Proteomic Series 1 included mock-infected controls, the parental HCMV strain, the US12-21 block deletion and defined mutants in US18, US19 and US20 (<xref ref-type="fig" rid="fig2">Figure 2</xref>, <xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Mass spectrometry quantified 7215 WCL and 1281 PM proteins. The extremely dynamic modulation of the host cell proteome observed during productive HCMV infection was consistent with previous findings (<xref ref-type="fig" rid="fig3">Figure 3</xref>)(<xref ref-type="bibr" rid="bib56">Weekes et al., 2014</xref>). The role of the entire US12 gene family was assessed by comparison of the HCMV US12-21 block deletion mutant with its parental virus. The impact was most noticeably focused on the PM, in that the majority of WCL proteins affected were also PM ‘hits’ (<xref ref-type="fig" rid="fig2">Figure 2</xref>). The heat map illustrating changes in protein abundance correspondingly appears more dynamic i.e. a higher proportion of proteins detected were regulated in response to the deletion of individual US12 family genes for the PM proteome than for the much larger set of proteins quantified in WCL samples (<xref ref-type="fig" rid="fig3">Figure 3</xref>). For a given PM protein modulated by the US12 gene family (<xref ref-type="fig" rid="fig4">Figure 4</xref>), comparable results were observed in WCL samples (<xref ref-type="fig" rid="fig5">Figure 5</xref>), suggesting that the US12 family regulates protein expression or stability of cell surface proteins.<fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.005</object-id><label>Figure 2.</label><caption><title>The US12 family targets numerous plasma membrane proteins.</title><p>Cells infected with HCMV (Merlin) or HCMV △US12-21 mutant were processed to give PM or WCL fractions and analyzed by TMT mass spectrometry. Scatter plot of proteins identified in the PM (panel <bold>A</bold>) or WCL fractions (panel <bold>B</bold>) respectively and quantified by 2 or more unique peptides. Fold change (△US12-21-infected fibroblasts/HCMV-infected cells) is shown as the log<sub>2</sub> ratio on the x-axis and the signal:noise on the y-axis as log<sub>10</sub>. Proteins unaltered by the US21-21 deletion locate at the center of the plots (0 log<sub>2</sub>/1 fold-change), whereas proteins to the left or right of center represent proteins down- or up-regulated by the US12-21 deletion respectively. Significance B was used to estimate <italic>p</italic> values (Cox et al., 2009). The 2 different alleles of MICA present in HFs were detected by this analysis.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.005">http://dx.doi.org/10.7554/eLife.22206.005</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig2-v3"/></fig><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.006</object-id><label>Figure 3.</label><caption><title>Hierarchical cluster analysis of all proteins quantified in proteomic series 1 and 2.</title><p>Zoomed regions are shown for clusters of interest.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.006">http://dx.doi.org/10.7554/eLife.22206.006</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig3-v3"/></fig><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.007</object-id><label>Figure 4.</label><caption><title>Proteomic analysis of cellular proteins targeted by US12 family members in PM samples.</title><p>(<bold>A</bold>-<bold>B</bold>) Workflows of proteomic series 1 and 2 respectively. (<bold>C</bold>-<bold>E</bold>) Quantitation of PM proteins in enriched KEGG pathways identified using DAVID. Relative abundance of each protein is expressed relative to the sample with the highest abundance (set to 1). NQ – not quantified. A number of the US12-21 mutant targets were also regulated by the US18 and US20 mutants (B7-H6, ULBP2, IL6ST, KIT, KITLG JAM3, ACVR1, ACVRL1, IFNGR1, JAM3, MPZL1, CXADR, ALCAM, SDC4, CD99, SDC1). A subset of these proteins were also regulated by the US14 and/or US16 mutants (KIT, KITLG, ACVR1, IFNGR1, JAM3, MPZL1, CD99, SDC1). We estimated p values for the ratios of each mutant compared to HCMV Merlin using Benjamini-Hochberg corrected Significance B values (<xref ref-type="bibr" rid="bib8">Cox and Mann, 2008</xref>): *p&lt;0.05, **p&lt;0.0001. For proteomic series 1, ratios were calculated as US12 family deletion mutant / average HCMV and for proteomic series 2, US12 family deletion mutant / HCMV. All proteins quantified by 2 or more peptides were included in this calculation. SDC1 was quantified by a single peptide in proteomic series 2.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.007">http://dx.doi.org/10.7554/eLife.22206.007</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig4-v3"/></fig><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.008</object-id><label>Figure 5.</label><caption><title>Individual US12-family proteins target key natural killer cell ligands, cell adhesion molecules and cytokines and their receptors in WCL samples.</title><p>(<bold>A</bold>–<bold>C</bold>) Quantitation of key US12 family targets in WCL samples (proteomic series 1 and 2 - comparative analysis of these proteins from PM samples is shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>). We generally observed similar results for proteins quantified in both PM and WCL samples. Relative abundance of each protein is expressed relative to the sample with the highest abundance (set to 1). NQ – not quantified. P values were calculated as described in <xref ref-type="fig" rid="fig4">Figure 4</xref>: *p&lt;0.05, **p&lt;0.0001. MICB was only quantified by 1 peptide in proteomic series 1, and MICA, JAM3 and SDC4 by one peptide in proteomic series 2.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.008">http://dx.doi.org/10.7554/eLife.22206.008</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig5-v3"/></fig></p><p>NK cells continually monitor the levels of inhibitory and activating ligands on the surface of potential targets, thus one of the roles of the US12 family in re-modeling the PM proteome is compatible with its role in directly impacting NK cell recognition. To gain an overview of pathways targeted, the online bioinformatics resource DAVID (Database for Annotation, Visualisation and Intergrated Discovery; <ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</ext-link>) was used to perform a KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway enrichment analysis on proteins rescued &gt;3 fold by the deletion of the US12-21 block (<xref ref-type="bibr" rid="bib15">Dennis et al., 2003</xref>; <xref ref-type="bibr" rid="bib27">Huang et al., 2009</xref>). Multiple KEGG pathways were significantly enriched (data not shown), including natural killer cell-mediated cytotoxicity (MICA, MICB, ULBP2, IFNGR1), cytokine-cytokine receptor interaction (IL6ST, KIT, KITLG, ACVRL1, ACVR1, IFNGR1) and cell adhesion molecules (CAMs; JAM3, ICOSLG, PTPRM, MPZL1, CXADR, ALCAM, SDC4, CD99, SDC1). The modulation of cell adhesion molecules and chemokines/cytokines may additionally impact NK cell recognition. A further NK ligand, B7-H6, was not identified by DAVID analysis, but was also regulated by the US12-21 mutant. While MICA is a recognized target of US18 and US20 (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>), the regulation of the NK cell activating ligands B7H6, MICB and ULBP2 by the US12 family are novel.</p></sec><sec id="s2-3"><title>Functional independence and co-operation exerted by family members</title><p>A substantial subset of the proteins regulated by the US12-21 block mutant were similarly modulated by US18 and US20 (<xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>), whereas US19 specifically targeted RALGPS2 (<xref ref-type="fig" rid="fig6">Figure 6</xref>). To determine the contribution of each individual US12 family member to the overall effects observed with the ‘block’ deletion mutant, Proteomic Series two compared infection with all the single gene deletion mutants (except the US19 deletion) to the parent HCMV (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Mass spectrometry quantified 7156 whole cell and 1312 PM proteins. We re-examined key candidate molecules identified by bioinformatic analysis of the US12-21 block deletion (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>). A striking feature of this data was that the majority of these target proteins were regulated by both US18 and US20, with a subset additionally regulated to a lesser degree by US14 and/or US16 (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref>). Other US12 family members also had important effects, with US12 and US13 mutants regulating the NKG2D ligands (NKG2DL) ULBP2 and MICB respectively, US14 mutant regulating PTPRM, and the US15 mutant regulating IL6ST (<xref ref-type="fig" rid="fig4">Figure 4C–E</xref> and <xref ref-type="fig" rid="fig6">Figure 6</xref>). Overall, the contribution made by a given family member varied dramatically ranging from the highly focused impact of US13 and US19 (one cellular target each) to the exceptionally promiscuous US20 (54 cellular targets) (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Where a given protein was quantified both in PM and WCL samples, generally similar changes were observed in both samples (<xref ref-type="fig" rid="fig4">Figure 4</xref> and <xref ref-type="fig" rid="fig5">5</xref>). Interestingly, MICA was regulated by the deletion of US12-21 block to a much greater extent than any of the single deletion mutants, implying that multiple US12 family members may need to act in concert to optimize control over certain cellular targets (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).<fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.009</object-id><label>Figure 6.</label><caption><title>Co-regulation of multiple cell surface proteins by &gt;1 US12 family gene.</title><p>Proteins that were rescued by deletion of each US12 family member in the PM fraction of proteomic Series 2 (i.e. not including US19) were analyzed to determine which were additionally targeted by one or more US12 family members. Proteins were plotted in a matrix with unique protein targets on the lower diagonal of the plot (US12 family member compared with itself) and common protein targets in intersections with other US12 members. To identify the highest confidence targets of the US12-21 family for the purposes of this analysis and to generate a shortlist of US12-21 family PM ‘hits’, we employed the following strategy: we included proteins (a) exhibiting at least 3-fold rescue upon deletion of a given US12 family member, quantified by at least two peptides and annotated by GO to indicate a PM location. (b) validated by a corresponding &gt;2 fold change in at least one of (i) deletion of the US12-21 block (proteomic series 1 or 3), (ii) the biological repeat of US18 or US20 in proteomic series 1, (iii) the corresponding gene deletion in WCL proteomic series 2. This strategy identified all proteins shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>. *US19 data was used from proteomic series 1.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.009">http://dx.doi.org/10.7554/eLife.22206.009</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig6-v3"/></fig></p><p>Infection with the US21 deletion mutant resulted in selective impairment of many late phase Tp3 and Tp5 (Temporal protein profile 3 and 5) HCMV proteins (<xref ref-type="bibr" rid="bib56">Weekes et al., 2014</xref>), for example UL32 and UL99/pp28, and elevated expression of pUS20, whereas the HCMV US12-21 block mutant did not recapitulate this effect (<xref ref-type="fig" rid="fig7">Figure 7</xref>, with further proteomic data searchable in Excel spreadsheet <xref ref-type="supplementary-material" rid="SD1-data">Supplemental file 1</xref>). Our data are consistent with deletion of the US21 structural gene impacting on the transcriptional control of US20 (data not shown), and may contribute to a potential growth defect observed for this particular mutant. Therefore the activation of NK cells in response to US21 mutant-infected targets cannot be assigned directly to an effect of US21 (<xref ref-type="fig" rid="fig1">Figure 1</xref>). A definitive assessment of the function of US21 will require an alternative approach.<fig id="fig7" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.010</object-id><label>Figure 7.</label><caption><title>Altered expression of US20, UL32 and UL99 levels in the US21 deletion mutant-infected fibroblasts.</title><p>Quantitation of US20, UL32 and UL99 in proteomic series 1–3 in both PM and WCL. Abundance of each protein is expressed relative to the sample with the highest abundance (set to 1). For proteomic series 1 and 2, p values were calculated as described in <xref ref-type="fig" rid="fig4">Figure 4</xref>: *p&lt;0.05, **p&lt;0.0001. US20 was only quantified by one peptide in proteomic series 1, WCL experiment.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.010">http://dx.doi.org/10.7554/eLife.22206.010</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig7-v3"/></fig></p><p>Of all PM proteins regulated &gt;3 fold by a member of the US12-21 family, 29% were regulated by 2 or more family members and 6% by 3 or more family members (<xref ref-type="fig" rid="fig6">Figure 6</xref>), although using a stringent 3-fold cutoff may underestimate the true incidence of co-regulation. Such co-regulation may suggest evolutionary pressure underpins the expansion of this gene family.</p></sec><sec id="s2-4"><title>Effect of lysosomal inhibition on US12 family targets</title><p>The majority of proteins that the US12 family down regulates from the PM are also lost from the WCL, consistent with post-translational proteolysis or an overall reduction in expression. We previously found that US20 targets the NKG2DL MICA for degradation in lysosomes (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>). The DAVID pathway analysis identified increases in lysosomal proteins within the PM fraction of △US20-infected cells; the list of lysosomal proteins included a number of cathepsins and ATPases (PSAP, CTSD, ATP6V1E1, ATP6V1H, NPC2) (data not shown). These data suggest a role for US20 in regulating intracellular endo-lysosomal vesicular transport.</p><p>To determine if this is a more general mechanism for the whole US12-21 family, HFFs were infected with HCMV, the US12-21 block deletion mutant or HCMV in the presence of the lysosomal protease inhibitor leupeptin for 12 hr prior to harvest, and protein expression was analyzed by 10-plex TMT at 24 hr, 48 hr and 72 hr post-infection (Proteomic Series 3, <xref ref-type="fig" rid="fig8">Figure 8A</xref>).<fig id="fig8" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.011</object-id><label>Figure 8.</label><caption><title>Multiple US12 gene family targets are degraded via the lysosomal pathway.</title><p>(<bold>A</bold>) Workflow of Proteomic Series 3. (<bold>B</bold>) Number of proteins targeted by the US12-21 block and additionally rescued &gt;2 fold in the dataset by the △US12-21 deletion mutant or rescued &gt;2 fold or &gt;1.5 fold by leupeptin treatment for both WCL and PM. C. Comparable degree of rescue of US12-21 target proteins by US12-21 deletion and leupeptin treatment. Quantitation of a subset of these proteins is shown relative to the maximum abundance (set to 1). p-values were calculated as described in <xref ref-type="fig" rid="fig4">Figure 4</xref>, for the ratios of leupeptin treatment or US12-21 deletion virus infection at each time point compared to the matched wild-type Merlin-infected control. *p&lt;0.05, **p&lt;0.0001. SDC1 was only quantified by one peptide.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.011">http://dx.doi.org/10.7554/eLife.22206.011</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig8-v3"/></fig></p><p>The △US12-21 ‘block’ deletion caused substantial shifts in WCL proteins, with &gt;80 proteins rescued &gt;2 fold at 48 hr, compared to the parent viral infection (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). Of these, 26% were also rescued &gt;2 fold and 51% &gt; 1.5 fold with leupeptin suggesting that the US12 family targets multiple host proteins to the lysosome. Leupeptin treatment had a more limited effect on rescuing PM proteins back to the the cell surface (<xref ref-type="fig" rid="fig8">Figure 8B</xref>), consistent with our previous observation of intracellular accumulation of MICA without protein relocalisation to the cell surface during treatment with leupeptin or other lysosomal inhibitors (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>). Of the 21 proteins identified in <xref ref-type="fig" rid="fig4">Figure 4</xref> within the key categories ‘natural killer cell-mediated cytotoxicity’, ‘cytokine-cytokine receptor interaction’ and ‘cell adhesion molecules’, 11 were rescued &gt;2 fold by leupeptin, with the remainder exhibiting 1.3–2-fold rescue (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). MICB was clearly rescued by leupeptin treatment (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). Interestingly, control of MICB and ULBP2 levels correlated with regulation of UL16 by US13 and US12 (<xref ref-type="fig" rid="fig9">Figure 9</xref>). However, leupeptin rescue of ULBP2 and UL16 was less convincing than for MICB (<xref ref-type="fig" rid="fig9">Figure 9</xref>). Although many cellular substrates of the US12 family are clearly being targeted for lysosomal degradation, there may be additional mechanisms by which this family regulates the PM proteome.<fig id="fig9" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.012</object-id><label>Figure 9.</label><caption><title>Regulation of UL16 levels by the US12 family.</title><p>Quantitation of UL16 in proteomic series 1–3 in both PM and WCL. Relative abundance of each protein is expressed relative to the sample with the highest abundance (set to 1). For proteomic series 1 and 2, p values were calculated as described in <xref ref-type="fig" rid="fig4">Figure 4</xref>: *p&lt;0.05, **p&lt;0.0001.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.012">http://dx.doi.org/10.7554/eLife.22206.012</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig9-v3"/></fig></p></sec><sec id="s2-5"><title>Validation of PM protein regulation by US12 family members</title><p>We used flow cytometry to validate a proportion of the various PM protein targets that are regulated by the US12 family (<xref ref-type="fig" rid="fig10">Figure 10</xref>). Next, we examined NKG2DL MICA and MICB (<xref ref-type="fig" rid="fig10">Figure 10</xref>). We found that MICA expression was rescued to a greater degree with the US12-21 block mutant than with the individual US18 or 20 deletion mutants (<xref ref-type="fig" rid="fig10">Figure 10</xref>). This is consistent with our previous analysis showing that a combined US18 and US20 deletion had a greater effect on cell surface MICA than single gene deletion mutants (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>). The US13 deletion mutant caused a minor, but consistent, elevation in cell surface expression of MICB. Other US12 family genes may yet contribute to regulating MICB, as there was a further increase in the US12-21 block mutant (<xref ref-type="fig" rid="fig10">Figures 10</xref> and <xref ref-type="fig" rid="fig4">4C</xref>).<fig id="fig10" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.013</object-id><label>Figure 10.</label><caption><title>Validation of cell surface proteins regulated by the US12 family.</title><p>Flow cytometry confirmed proteomic data for proteins representative of each category enriched in the DAVID analysis. Staining in mock/US12 family member deletion mutant infections (blue line) is shown relative to the parental HCMV infection (red line). Flow cytometry was carried out for cell surface expression of MHC I (W6/32) as a control for HCMC infection and isotype antibody staining controls (with directly PE-conjugated IgG1, IgG2a or IgG2b antibodies or for unconjugated antibodies mIgG and an anti-mouse-AF647 conjugated secondary antibody). Infected cells were assessed by the % cells with down-regulated MHC I compared to the mock-infected cells (HCMV 94%, ΔUS12 94%, ΔUS13 94%, ΔUS14 83%, ΔUS15 95%, ΔUS16 97%, ΔUS17 85%, ΔUS18 94%, ΔUS19 96%, ΔUS20 94%, ΔUS21 94%, ΔUS12-21 96%). Results are representative of at least two independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.013">http://dx.doi.org/10.7554/eLife.22206.013</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig10-v3"/></fig></p></sec><sec id="s2-6"><title>B7-H6 is an NK cell activating ligand targeted by US18 and US20</title><p>The fact that, in addition to targeting MICA, US18 and US20 together are also implicated in targeting B7-H6 is extraordinary. B7-H6 is a known ligand for NKp30 and exogenous expression in fibroblasts increased NK degranulation (<xref ref-type="fig" rid="fig11">Figure 11A–C</xref>). Ectopic expression of US20, and to a lesser extent US18, from adenovirus vectors reduced levels of exogenously expressed B7-H6 detected by immunoblotting (<xref ref-type="fig" rid="fig11">Figure 11D</xref>). Both PM and WCL expression of B7-H6 was induced by the HCMV US18, US20 and US12-21 deletion mutants but not by the parental virus (<xref ref-type="fig" rid="fig4">Figure 4C</xref>, <xref ref-type="fig" rid="fig5">Figure 5A</xref>), which was confirmed by flow cytometry and immunoblot (<xref ref-type="fig" rid="fig10">Figures 10</xref> and <xref ref-type="fig" rid="fig12">12A</xref>). B7-H6 is therefore induced as a ‘stress ligand’ during productive infection, but its expression is controlled by US18 and US20, acting in concert, to target it for proteolysis (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). Being the dominant ligand for the NK activating receptor NKp30, B7-H6 is potentially a critical target for HCMV.<fig id="fig11" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.014</object-id><label>Figure 11.</label><caption><title>Adenovirus expressed B7-H6 regulates NK cell activation and B7-H6 levels are regulated by ectopically-expressed US18 and US20.</title><p>(<bold>A</bold>) HF-CARs were infected with control (RAd-CTRL) or B7-H6-expressing (RAd-B7-H6) adenovirus vectors (MOI 5). Cells were harvested 48 h p.i. and used as targets in a CD107 degranulation assay with buffy-coat derived PBMC from 3 separate donors in duplicate or triplicate. Results (shown as mean and SD) were analyzed by unpaired two-tailed Student’s T-test. ***p&lt;0.001, ****p&lt;0.0001. (<bold>B</bold> and <bold>C</bold>) HF-CARs were infected with control (RAd-CTRL) or B7-H6-expressing (RAd-B7-H6) adenovirus vectors (MOI 5). Cells were harvested 48 h p.i. and B7-H6 cell surface expression analyzed by flow cytometry (<bold>B</bold>) or western blot (<bold>C</bold>). Results are representative of at least 2 independent experiments. (<bold>D</bold>) HF-CARs were infected with adenovirus control (CTRL), US18-expressing adenovirus, US20-expressing adenovirus or a combination of both US18 and US20 (MOI 5 each, made up to a total MOI of 10 with RAd-CTRL). After 24 hr incubation, HF-CARs were infected with adenovirus control (CTRL) or B7-H6-expressing adenovirus (B7–H6) at MOI 5 as indicated before incubation for a further 48 hr. Whole cell lysates were prepared and analysed by immunoblotting with the antibodies indicated. Results are representative of two independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.014">http://dx.doi.org/10.7554/eLife.22206.014</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig11-v3"/></fig><fig id="fig12" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.015</object-id><label>Figure 12.</label><caption><title>Differences in B7-H6 levels on HCMV US12 family deletion mutant-infected cells regulate NKp30-mediated responses.</title><p>(<bold>A</bold>) Whole cell lysates were prepared from mock, HCMV or the series of US12 family deletion mutant infected fibroblasts and analyzed by immunoblotting with antibodies specific for B7-H6 (CH31) or actin. Results are representative of two independent experiments. (<bold>B</bold>) An NKp30-responsive 2B4 reporter cell line containing a NFAT-GFP reporter construct (CT299) was incubated for 24 hr with mock, HCMV or the series of US12 family deletion mutant infected fibroblasts in triplicate. Fixed cells were then analyzed for GFP fluorescence by flow cytometry compared to cells incubated with no target fibroblasts. Results are expressed as the % GFP positive reporter cells (mean and SD) and were analyzed by unpaired two-tailed Student’s T-test. Results are representative of two independent experiments. (<bold>C</bold>) HF-TERTs were transfected with control (<bold>C</bold>) or B7-H6 (B7) siRNAs for 24 hr prior to infection with the parent HCMV, △US18, △US20 or △US12-21 mutants for 72 hr. Cells were then incubated for 24 hr with CT299 NKp30 reporter cells in triplicate and GFP<sup>+</sup> cells determined by flow cytometry, and analysed by unpaired two-tailed Student’s t-test. Results (mean and SD) are representative of two independent experiments. (<bold>D</bold>) HF-TERTs infected with HCMV, △US18, △US20 or △US12-21 mutants were incubated for 24 hr with CT299 NKp30 reporter cells, in the presence isotype control (<bold>C</bold>) or B7-H6 blocking antibodies (B7) in triplicate, GFP<sup>+</sup> cells determined by flow cytometry and analyzed by unpaired two-tailed Student’s t-test. Results (mean and SD) are representative of two independent experiments.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.015">http://dx.doi.org/10.7554/eLife.22206.015</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig12-v3"/></fig></p><p>We investigated the effect of the US12 family members upon activation of an NKp30-responsive reporter cell line, and found that the presence of US18 and US20 was required to inhibit reporter activity (<xref ref-type="fig" rid="fig12">Figure 12B</xref>). Reporter cell fluorescence could be inhibited either by transfection of B7-H6 specific siRNA or by use of a B7-H6 specific blocking antibody (CH31) (<xref ref-type="fig" rid="fig12">Figure 12C and D</xref> respectively). The presence of both US18 and US20 was required to prevent B7-H6 activating the NKp30 reporter function.</p><p>We sought to differentiate the functional impact exerted by US18 and US20 on B7-H6 and MICA. B7-H6 knockdown in cells infected with HCMV US18 and US20 deletion mutants was correspondingly able to reduce donor NK cell activation (<xref ref-type="fig" rid="fig13">Figure 13A and B</xref>). The impact of B7-H6 knockdown on the HCMV US12-21 block mutant was more variable and consistent with the US12 gene family encoding additional NK modulating functions (<xref ref-type="fig" rid="fig13">Figure 13B</xref>, <xref ref-type="fig" rid="fig1">Figure 1</xref>). A B7-H6 blocking antibody had an even more pronounced effect, reducing NK activation in response to the US18, US20 and US12-21 deletion mutants to levels of the parental HCMV control (<xref ref-type="fig" rid="fig13">Figure 13C</xref>). These results are consistent with B7-H6 playing a major role in NK cell recognition of HCMV-infected cells, a function that is countered by the US12 family members US18 and US20.<fig id="fig13" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.016</object-id><label>Figure 13.</label><caption><title>B7-H6 regulation has a major effect on NK activation in response to HCMV infection.</title><p>(<bold>A</bold> and <bold>B</bold>) HF-TERTs were transfected with control (<bold>C</bold>) or B7-H6 (B7) siRNAs for 24 hr prior to infection with the parent HCMV, △US18, △US20 or △US12-21 mutants. Cells were harvested 72 h p.i. and B7-H6 cell surface expression analyzed by flow cytometry (E) or used as targets in a CD107 degranulation assay with donor-derived PBMC in triplicate (F). Results (mean and SD) were analyzed by unpaired two-tailed Student’s t-test and are representative of two independent experiments using 2 separate donors in each. Infected cells were assessed by the % cells with down-regulated MHC I compared to the mock-infected cells (HCMV CTRL siRNA 95%, ΔUS18 CTRL siRNA 91%, ΔUS20 CTRL siRNA 93%, ΔUS12-21 CTRL siRNA 86%, HCMV B7-H6 siRNA 96%, ΔUS18 B7-H6 siRNA 84%, ΔUS20 B7-H6 siRNA 96%, ΔUS12-21 B7-H6 siRNA 79%). (<bold>C</bold>) HF-TERTs infected with HCMV, △US18, △US20 or △US12-21 mutants were used as targets in a CD107 degranulation assay with donor-derived PBMC, in the presence isotype control (<bold>C</bold>) or B7-H6 (B7) blocking antibodies in triplicate. Results (mean and SD) were analyzed by unpaired two-tailed Student’s t-test and are shown for two separate donors. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.016">http://dx.doi.org/10.7554/eLife.22206.016</ext-link></p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-22206-fig13-v3"/></fig></p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The HCMV genome contains 15 gene families of various sizes that have been acquired during evolution to promote virus persistence. Clusters of US12-related genes can be detected in cytomegaloviruses of New World primates, i.e. Green Monkey and Owl Monkey CMVs, thus the capture and expansion of an ancestral precursor presumably took place over 41 million years ago (<xref ref-type="bibr" rid="bib14">Davison et al., 2013</xref>). Within Cynomolgus and Rhesus macaques (Old World primates), chimpanzee and human CMVs, the US12 family is maintained as a well conserved contiguous tandem array of 10–11 genes located in the same relative position on each genome. Amongst circulating HCMV clinical strains, the US12 family exhibits relatively high levels of sequence conservation and genetic integrity (<xref ref-type="bibr" rid="bib44">Sijmons et al., 2015</xref>).</p><p>The complexity of the HCMV genome, its restricted host range in vitro and protracted replication cycle has frustrated studies into HCMV gene function. However, the advent of high-resolution multiplexed proteomics is revolutionizing our understanding of how HCMV orchestrates host cell gene expression and evades host defenses (<xref ref-type="bibr" rid="bib56">Weekes et al., 2014</xref>; <xref ref-type="bibr" rid="bib26">Hsu et al., 2015</xref>). By systematically analyzing a bespoke panel of HCMV deletion mutants, we have discovered that the US12 family selectively targets a broad range of plasma membrane proteins that include, not only NK cell activating ligands, but also T-cell co-stimulatory molecules, cell adhesion molecules, and cytokine/cytokine receptors. The diversity of proteins targeted by many of the US12 family implies a broad strategy of redirecting cell surface receptors. A sizeable proportion of targeted plasma membrane proteins do not accumulate internally, but are degraded in lysosomes, as indicated by rescue with the inhibitor leupeptin. The overlap that exists between US12 gene family targets with those of the KSHV K5 viral E3 ubiquitin ligase (MICA, MICB, B7 family, ALCAM, IFNGR1, PTPRM, EPHA2, CD99, MPZL1/2) could represent convergent evolution and/or targeting of similar cellular pathways (<xref ref-type="bibr" rid="bib49">Timms et al., 2013</xref>).</p><p>The US12 family has a major impact on NK cell recognition with four US12 family members US12, US14, US18 and US20 consistently contributing toward significant levels of NK cell protection. Although the HCMV US21 deletion mutant also scored in functional assays, this could be due to enhanced expression of pUS20 associated with this construct. The NKG2DL MICB and ULBP2 are strongly upregulated during HCMV infection, but fail to reach the cell surface as they are retained in the ER by the NK evasion function gpUL16 (<xref ref-type="bibr" rid="bib43">Rolle et al., 2003</xref>). Our proteomic data reveal that deletion of US12, US13 and US20 leads to increased cell surface and intracellular expression of MICB, ULBP2 and UL16 itself (<xref ref-type="fig" rid="fig9">Figure 9</xref>). These observations are consistent with US12 family members acting in concert to direct UL16, MICB and ULBP2 towards proteolytic degradation, with leupeptin treatment clearly able to rescue MICB, and this may contribute to the NK evasion properties of US12 (<xref ref-type="fig" rid="fig1">Figure 1</xref>). They also imply that some of the effects of the US12 family could be the result of co-operation with other HCMV genes. There is some precedent for this situation, although not previously on such a wide scale, as co-operation between US2 and UL141 was observed in the proteasomal degradation of some protein targets e.g. CD112 (<xref ref-type="bibr" rid="bib26">Hsu et al., 2015</xref>). None of the US14 targets are recognized NK cell ligands, suggesting that this gene product utilizes a novel NK evasion mechanism.</p><p>B7-H6 is the major ligand identified for the natural cytotoxicity receptor (NCR) NKp30 and a tumor antigen (<xref ref-type="bibr" rid="bib1">Brandt et al., 2009</xref>). Previously, B7-H6 expression was shown to be induced by inflammatory stimuli, for example pro-inflammatory cytokines and bacterial-derived toll-like receptor (TLR) ligands (<xref ref-type="bibr" rid="bib33">Matta et al., 2013</xref>). We show here that B7-H6 expression is induced as a stress protein by HCMV infection (and potentially other virus infections) and that US18 and US20 act together to suppress cell surface expression of B7-H6 in the context of HCMV, thereby inhibiting NK cell activation. US18 and US20 were also able to regulate exogenously expressed B7-H6 when expressed individually. Therefore, they appear to target B7-H6 directly and not cellular pathways leading to the expression of B7-H6. The control of B7-H6 is likely to be of major significance as NKp30 is expressed on γδ T-cells (Vδ2<sup>-</sup>) that are induced during HCMV infection post-transplantation and correlate with control of disease (<xref ref-type="bibr" rid="bib36">Merville et al., 2000</xref>; <xref ref-type="bibr" rid="bib30">Lafarge et al., 2001</xref>; <xref ref-type="bibr" rid="bib6">Correia et al., 2011</xref>).</p><p>The US12 family clearly impacts on a broad range of cellular functions including adhesion molecules and cytokine receptors. Many of these adhesion molecules play roles in co-stimulation or immune synapse formation of T-cells e.g. ALCAM, ICOSLG, CXADR (<xref ref-type="bibr" rid="bib24">Hassan et al., 2004</xref>; <xref ref-type="bibr" rid="bib54">Wang et al., 2000</xref>; <xref ref-type="bibr" rid="bib58">Witherden et al., 2010</xref>). The US12 family targets pro-inflammatory mediators, such as multiple members of the tumour necrosis factor receptor (TNFR) superfamily (TNFRSF8, TNFRSF12A, NGFR, LTBR), gp130 (IL6ST), the IL-6 receptor signaling receptor, pannexin-1 (PANX1) and the TLR4 ligand high-mobility group protein B1 (HMGB1) (<xref ref-type="bibr" rid="bib10">Croft et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Kanneganti et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Park et al., 2004</xref>). IL6ST signaling may also have antiviral effects in the context of HCMV (<xref ref-type="bibr" rid="bib23">Harwardt et al., 2016</xref>), which was suggested by the finding that disruption of gp130 STAT3 binding resulted in IFN-like signaling through STAT1(<xref ref-type="bibr" rid="bib7">Costa-Pereira et al., 2002</xref>).</p><p>The closest cellular homologues to the US12 family are the TMBIM family with recognised functions in controlling apoptosis, ER stress, ROS production, actin production, glucose metabolism and protein trafficking (<xref ref-type="bibr" rid="bib42">Rojas-Rivera and Hetz, 2015</xref>). The US12 family may have arisen through an ‘accordion’ gene expansion from a ‘captured’ ancestor TMBIM gene. Out of the entire US12 family, US21 displays the highest level of homology with TMBIM1/4, with the homologous region limited to the transmembrane domain and loops (unpublished observations, [<xref ref-type="bibr" rid="bib32">Lesniewski et al., 2006</xref>; <xref ref-type="bibr" rid="bib25">Holzerlandt et al., 2002</xref>]). The divergence of the US12 and TMBIM families is also reflected in their different membrane topologies, as TMBIM family have cytosolic N- and C-termini with six full transmembrane spanning regions, and US20 has a cytosolic N-terminus and lumenal C-terminus (<xref ref-type="bibr" rid="bib3">Carrara et al., 2012</xref>; <xref ref-type="bibr" rid="bib4">Cavaletto et al., 2015</xref>). The functional relevance of the US12 family/TMBIM homology remains unclear, although it may represent a ‘functional scaffold’ (<xref ref-type="bibr" rid="bib32">Lesniewski et al., 2006</xref>), as a number of TMBIMs also target proteins for lysosomal degradation (<xref ref-type="bibr" rid="bib31">Lee et al., 2012</xref>; <xref ref-type="bibr" rid="bib59">Yamaji et al., 2010</xref>).</p><p>Our data indicate that the US12 family targets multiple host immune ligands, consistent with the family having arisen, been selected and diverged in function as a consequence of immune selection. US12 family genes differ from the majority of characterised immune evasion viral genes, as they act together and do not exhibit single gene effects. The targeting of multiple proteins by a HCMV immunevasin or co-operation between HCMV gene products is not unprecedented, but was not previously observed on this scale or with this diversity of target proteins (<xref ref-type="bibr" rid="bib51">Tomasec et al., 2005</xref>; <xref ref-type="bibr" rid="bib41">Prod'homme et al., 2010</xref>; <xref ref-type="bibr" rid="bib45">Smith et al., 2013</xref>; <xref ref-type="bibr" rid="bib26">Hsu et al., 2015</xref>). The majority of US12 family targets contain an immunoglobulin-like domain, including the MHC I-related proteins, MICA and B7-H6. Our data highlight the importance that HCMV gene families are likely to play in terms of HCMV persistence in vivo and identifies the US12 family as a critical region for regulation of the host immune response.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Ethics statement</title><p>Healthy adult volunteers provided blood for this study following written informed consent (approved by the Cardiff University School of Medicine Ethics Committee Ref. no: 10/20) or buffy coats provided by the Welsh Blood Service, following informed consent.</p></sec><sec id="s4-2"><title>Cell lines</title><p>Human foreskin fibroblasts (HFFs), HFFs immortalized by human telomerase (HF-TERT), HF-TERTs transfected with the Coxsackie-adenovirus receptor (HF-CAR), were maintained at 37°C in 5% CO<sub>2</sub> in growth medium (Dulbecco’s minimal essential medium (DMEM) supplemented with penicillin/streptomycin and 10% fetal calf serum (Invitrogen, Paisley, UK) (<xref ref-type="bibr" rid="bib35">McSharry et al., 2001</xref>).</p></sec><sec id="s4-3"><title>Viruses</title><p>HCMV deletion mutants were generated by recombineering of the bacterial artificial chromosome (BAC) of HCMV strain Merlin (GenBank accession number GU179001.1), as described previously (<xref ref-type="bibr" rid="bib47">Stanton et al., 2010</xref>). Strain Merlin contains the complete genetic complement of HCMV, and is frame shifted in two genes (RL13<sup>–</sup>, UL128<sup>–</sup>). Alterations to the BAC were monitored by local PCR and Sanger sequencing, and the entire genomes of the viruses were confirmed by Illumina sequencing as described previously (<xref ref-type="bibr" rid="bib37">Murrell et al., 2016</xref>). Details of the viruses are provided in <xref ref-type="table" rid="tbl1">Table 1</xref> and a list of primers used in their construction and local sequencing of the BACs are provided in <xref ref-type="table" rid="tbl2">Tables 2</xref> and <xref ref-type="table" rid="tbl3">3</xref> respectively. Primers used in the construction of the HCMV △US18 and △US20 deletion mutants were detailed previously (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>).<table-wrap id="tbl2" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.017</object-id><label>Table 2.</label><caption><p>Primers used in the construction of the HCMV US12 deletion mutants library.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.017">http://dx.doi.org/10.7554/eLife.22206.017</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th style="background: #fcfafa;" valign="top"><bold>Primer</bold></th><th style="background: #fcfafa;" valign="top"><bold>Sequence (5’ &gt; 3’)</bold></th></tr></thead><tbody><tr><td style="background: #fcfafa;" valign="top"><italic>US12 GalK For</italic></td><td style="background: #fcfafa;" valign="top">GCGGGGGACAAAGGACAGTACGACAGATTAGGTGATAGAAACGTTTTTTTCCTGTTGACAATTAATCATCGGCA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US12 GalK Rev</italic></td><td style="background: #fcfafa;" valign="top">AAACTTGCCGGGTACCTGAAGCCCCGACGACTGTTCGTCGAGCACCCG TCTCAGCACTGTCCTGCTCCTT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US12 Delete</italic></td><td style="background: #fcfafa;" valign="top">GCGGGGGACAAAGGACAGTACGACAGATTAGGTGATAGAAACGTTTTTTTGACGGGTGCTCGACGAACAGTCGTCGGGGCTTCAGGTACCCGGCAAGTTT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US13 GalK For</italic></td><td style="background: #fcfafa;" valign="top">CTTCAGGTACCCGGCAAGTTTTATAGAGAAAGGGGGACGATGGGTGGTGGCCTGTTGACAATTAATCATCGGCA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US13 GalK Rev</italic></td><td style="background: #fcfafa;" valign="top">GAAGACTCCACCGAGACGCTCACCCGTTCACTCGGGCGCATCACCCGC CTTCAGCACTGTCCTGCTCCTT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US13 Delete</italic></td><td style="background: #fcfafa;" valign="top">CTTCAGGTACCCGGCAAGTTTTATAGAGAAAGGGGGACGATGGGTGGTGGAGGCGGGTGATGCGCCCGAGTGAACGGGTGAGCGTCTCGGTGGAGTCTTC</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US14 GalK For</italic></td><td style="background: #fcfafa;" valign="top">GAGTGAACGGGTGAGCGTCTCGGTGGAGTCTTCTTATAAACCAGCGGG TCCCTGTTGACAATTAATCATCGGCA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US14 GalK Rev</italic></td><td style="background: #fcfafa;" valign="top">CTGTAGCTTCGAGACCTTGCGGATACGCCGCCGGGCGCTGCGGTCCCG ACTCAGCACTGTCCTGCTCCTT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US14 Delete</italic></td><td style="background: #fcfafa;" valign="top">GAGTGAACGGGTGAGCGTCTCGGTGGAGTCTTCTTATAAACCAGCGGGTCGTCGGGACCGCAGCGCCCGGCGGCGTATCCGCAAGGTCTCGAAGCTACAG</td></tr><tr><td style="background: #fcfafa;" valign="top">US15 GalK For</td><td style="background: #fcfafa;" valign="top">CTCCATGTCGGGACCGCAGCGCCCGGCGGCGTATCCGCAAGGTCTCGAAGCCTGTTGACAATTAATCATCGGCA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US15 GalK Rev</italic></td><td style="background: #fcfafa;" valign="top">CGGAACTGGTTTTCGGACAGAGCAGCCGTTTCCAGAGAACGCAGCGCA CCTCAGCACTGTCCTGCTCCTT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US15 Delete</italic></td><td style="background: #fcfafa;" valign="top">CTCCATGTCGGGACCGCAGCGCCCGGCGGCGTATCCGCAAGGTCTCGAAGGGTGCGCTGCGTTCTCTGGAAACGGCTGCTCTGTCCGAAAACCAGTTCCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US16 GalK For</italic></td><td style="background: #fcfafa;" valign="top">CGTTCTCTGGAAACGGCTGCTCTGTCCGAAAACCAGTTCCGAACGAAAATCCTGTTGACAATTAATCATCGGCA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US16 GalK Rev</italic></td><td style="background: #fcfafa;" valign="top">CCCCACGGATCTCGCGTCTTAGACGCGCGGTCATATAGCCTCCGGCTG TCTCAGCACTGTCCTGCTCCTT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US16 Delete</italic></td><td style="background: #fcfafa;" valign="top">CGTTCTCTGGAAACGGCTGCTCTGTCCGAAAACCAGTTCCGAACGAAAATGACAGCCGGAGGCTATATGACCGCGCGTCTAAGACGCGAGATCCGTGGGG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US17 GalK For</italic></td><td style="background: #fcfafa;" valign="top">TTGGTGGAGACGGCCGGCGCGGCGGGTGGGGGAAACGACGAGTTTTTCCGCCTGTTGACAATTAATCATCGGCA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US17 GalK Rev</italic></td><td style="background: #fcfafa;" valign="top">ACACTCTATAAACGGTTTCTCATACGCGCCTTTTGATAGCCACCGCCG TCTCAGCACTGTCCTGCTCCTT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US17 Delete</italic></td><td style="background: #fcfafa;" valign="top">TTGGTGGAGACGGCCGGCGCGGCGGGTGGGGGAAACGACGAGTTTTTCCGGACGGCGGTGGCTATCAAAAGGCGCGTATGAGAAACCGTTTATAGAGTGT</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US19 SacB For</italic></td><td style="background: #fcfafa;" valign="top">CAGCACCCGGTTACCGCGGATTTGATTGACGTCACGAGTGTGGTCAAACCGTGGCGGCACCCTGTATCCGACCCGTCGCCTGTGACGGAAGATCACTTCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US19 SacB Rev</italic></td><td style="background: #fcfafa;" valign="top">GCTACGCCTCTATGTCGAAAATGTGGCTTTATTCATCGGCATGTACCATCTTCTGAGGCTCTGGTTGTGGAGCCCATGACTGAGGTTCTTATGGCTCTTG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US19 Delete</italic></td><td style="background: #fcfafa;" valign="top">ACGTCACGAGTGTGGTCAAACCGTGGCGGCACCCTGTATCCGACCCGTCGGGCGACAAGCGCGGCTGCTGTGAAAACGGGCGCGGTTTTATAGGCATTAG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US21 SacB For</italic></td><td style="background: #fcfafa;" valign="top">TGCGGCGCACCTACCCTTCTCTTATACACAAGCGAGCGAGTGGGGCACGGTGACGTGGTCACGCCGCGGACACGTCGACCTGTGACGGAAGATCACTTCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US21 SacB Rev</italic></td><td style="background: #fcfafa;" valign="top">CAGCGCCCACACTGCTCAGACGACGGTCGCTGCGACGGTCGCTGCCACAGCAGCGGCGTCGCCCCAGTTCGTCTCCTAACTGAGGTTCTTATGGCTCTTG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US21 Delete</italic></td><td style="background: #fcfafa;" valign="top">CAAGCGAGCGAGTGGGGCACGGTGACGTGGTCACGCCGCGGACACGTCGAGGCGGCAACGCCGGCGGTTATCGCCGAGATTCGTCTAAATACACGAAGCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US12-21 Delete</italic></td><td style="background: #fcfafa;" valign="top">GCGGGGGACAAAGGACAGTACGACAGATTAGGTGATAGAAACGTTTTTTTGGCGGCAACGCCGGCGGTTATCGCCGAGATTCGTCTAAATACACGAAGCG</td></tr></tbody></table></table-wrap><table-wrap id="tbl3" position="float"><object-id pub-id-type="doi">10.7554/eLife.22206.018</object-id><label>Table 3.</label><caption><p>Primers used in the local sequencing of the HCMV US12 deletion mutant library</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.018">http://dx.doi.org/10.7554/eLife.22206.018</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th style="background: #fcfafa;" valign="top"><bold>Primer</bold></th><th style="background: #fcfafa;" valign="top"><bold>Sequence (5’ &gt; 3’)</bold></th></tr></thead><tbody><tr><td style="background: #fcfafa;" valign="top"><italic>US12 Seq For</italic></td><td style="background: #fcfafa;" valign="top">CCCTGTCTAGACTCAAAAGCTG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US12 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">ATCGTCCCCCTTTCTCTATA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US13 Seq For</italic></td><td style="background: #fcfafa;" valign="top">GCCGAGTGGCTCGCC</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US13 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">CTGGGCACCTATCATCATTA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US14 Seq For</italic></td><td style="background: #fcfafa;" valign="top">GGAGGGAAGCCCATTGC</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US14 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">TCATTACCTGTCTAGCCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US15 Seq For</italic></td><td style="background: #fcfafa;" valign="top">CGGACGCGGCTTCC</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US15 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">GTCGCTACAGCTCTTTATTA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US16 Seq For</italic></td><td style="background: #fcfafa;" valign="top">GGGGCACGTAGATGACCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US16 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">CTCATTAGACAAACTCATCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US17 Seq For</italic></td><td style="background: #fcfafa;" valign="top">GTCTAAGACGCGAGATCCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US17 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">CCCAGTAGACAGACAGAACA</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US19 Seq For</italic></td><td style="background: #fcfafa;" valign="top">GGAGCGGCACGATGGTGACC</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US19 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">TCTGCCCACCTAACCAATGC</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US21 Seq For</italic></td><td style="background: #fcfafa;" valign="top">GCTGAAAGATGAAGATGGCG</td></tr><tr><td style="background: #fcfafa;" valign="top"><italic>US21 Seq Rev</italic></td><td style="background: #fcfafa;" valign="top">ACCCGACCAGATGGGAGACG</td></tr></tbody></table></table-wrap></p><p>The replication-deficient adenovirus vector (RAd-CTRL, pAL1253) and adenovirus vectors expressing US18 (RAd-US18) and US20 (RAd-US20) from the Merlin strain of HCMV have been described previously (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>). A B7-H6 (NCR3LG1) expressing adenovirus was generated by synthesising the B7-H6 CDS (corresponding to Accession number NM_001202439.2, bases 209–1573 retaining the stop codon) with 5’ and 3’ arms of homology to the AdZ BAC (corresponding to the For and Rev primers used in the AdZ recombineering protocol) (<xref ref-type="bibr" rid="bib46">Stanton et al., 2008</xref>) and flanking EcoRI sites (gene synthesis from Genscript, Piscataway, NJ). The cassette containing the B7-H6 CDS and both arms of homology was released from the pUC57 vector by EcoRI digest, gel purified and inserted into pAL1141 by recombineering to produce pAL1593. BAC DNA of pAL1593 purified by maxiprep (Macherey-Nagel, Dueren, Germany) was transfected into 293 TREX to generate the adenovirus, as previously described (<xref ref-type="bibr" rid="bib46">Stanton et al., 2008</xref>).</p></sec><sec id="s4-4"><title>HCMV infections</title><p>For proteomic analysis, 24 hr prior to each infection 1.5 × 10<sup>7</sup> HFFs were plated in a 150 cm<sup>2</sup> flask. Cells were sequentially infected at multiplicity of infection 10 with HCMV strain Merlin &gt;90% of cells were routinely infected using this approach as assessed by MHC I down-regulation. Infections were staggered such that all flasks were harvested simultaneously. For NK cell degranulation, flow cytometry and western blot analyses, cells were seeded in growth medium at appropriate cell densities (1 × 10<sup>6</sup> cells for a 25 cm<sup>2</sup> flask). The following day, the cells were infected with virus at the required multiplicity of infection in an appropriate volume of growth medium (2 ml for a 25 cm<sup>2</sup> flask) for 2 hr on a rocker at 37°C in 5% CO<sub>2</sub>. The innoculum was then replaced with fresh growth medium (7 ml for a 25 cm<sup>2</sup> flask), and the cells were incubated for the required times. Fetal calf serum was omitted from the growth medium for mock and HCMV infections. For inhibitor studies, cells were treated 12 hr prior to harvesting with lysosomal inhibitors (leupeptin 200 µM, Merck Millipore, Watford, UK; Cat. no. 108975) in DMEM. For siRNA experiments, cells were seeded in a 25 cm<sup>2</sup> flask at 8 × 10<sup>5</sup> cells/flask 24 hr prior to transfection and then transfected in Optimem medium (Invitrogen) with 120 pmol B7-H6 (SI04761351, Hs_DKFZp686O24166_5, Qiagen, Manchester, UK﻿) or control siRNA (AllStar Negative Control siRNA, 1027281, Qiagen) using Lipofectamine RNAiMax (Invitrogen) for a further 24 hr before infection with HCMV (MOI 20) in serum free DMEM for a further 72 hr.</p></sec><sec id="s4-5"><title>Adenovirus infections</title><p>Adenovirus infections were carried out in HF-CAR (MOI 5). Cells were seeded in growth medium at appropriate cell densities (1 × 10<sup>6</sup> cells for a 25 cm<sup>2</sup> flask). The following day, the cells were infected with virus at the required multiplicity of infection in an appropriate volume of growth medium (2 ml for a 25 cm<sup>2</sup> flask) for 2 hr on a rocker at 37°C in 5% CO<sub>2</sub>. The inoculum was then replaced with fresh growth medium (7 ml for a 25 cm<sup>2</sup> flask), and the cells were incubated for the required times.</p></sec><sec id="s4-6"><title>Protein isolation, peptide labeling with tandem mass tags</title><p>Preparation of PM and WCL protein and peptide samples was performed as described previously (<xref ref-type="bibr" rid="bib56">Weekes et al., 2014</xref>). For PM analysis, 100% of each tryptic peptide sample was labeled with TMT reagent, and 6 fractions generated from combined peptide samples by tip-based strong cation exchange. For WCL analysis, cells were lysed in 6 M Guanidine/50 mM HEPES pH8.5 then processed as described (<xref ref-type="bibr" rid="bib56">Weekes et al., 2014</xref>). Proteins were digested with LysC then Trypsin. Peptides were labeled with TMT reagent, and 12 fractions generated by high pH reversed phase HPLC.</p></sec><sec id="s4-7"><title>Mass spectrometry and data analysis</title><p>Mass spectrometry and data analysis were performed as described previously (<xref ref-type="bibr" rid="bib56">Weekes et al., 2014</xref>). Briefly, we performed mass spectrometry using an Orbitrap Fusion, and quantified TMT reporter ions from the MS3 scan (<xref ref-type="bibr" rid="bib34">McAlister et al., 2012</xref>; <xref ref-type="bibr" rid="bib50">Ting et al., 2011</xref>). Peptides were identified and quantified using a Sequest-based in-house software pipeline. A combined database was searched, consisting of: (a) human Uniprot, (b) Merlin strain HCMV Uniprot and (c) all additional novel HCMV ORFs (<xref ref-type="bibr" rid="bib48">Stern-Ginossar et al., 2012</xref>). Peptides spectral matches (PSM) were filtered to a 1% peptide false discovery rate (FDR) using linear discriminant analysis (<xref ref-type="bibr" rid="bib28">Huttlin et al., 2010</xref>). The resulting dataset was further collapsed to a final protein-level FDR of 1%. Protein assembly was guided by principles of parsimony. Where all PSM from a given HCMV protein could be explained either by a canonical gene or novel ORF, the canonical gene was picked in preference. Proteins were quantified by summing TMT reporter ion counts across all matching PSM after filtering based on isolation specificity (<xref ref-type="bibr" rid="bib39">Pease et al., 2013</xref>). Reverse and contaminant proteins were removed, and protein quantitation values were exported for normalization and further analysis in Excel. Where all PSMs from a given HCMV protein could be explained either by a canonical gene or novel ORF, the canonical gene was picked in preference. For five viral proteins that had related novel ORFs (N-terminal extensions of the viral protein), some peptides could either have originated either from the canonical protein or the novel ORF. In these cases, each of the novel ORFs were quantified based only on unique peptides that could only have originated from that ORF. Peptides that could either have originated from the canonical protein or the novel ORF were assigned to the canonical protein. We estimated p values for the ratios of each mutant compared to HCMV Merlin or leupeptin-treated cells infected with HCMV Merlin to HCMV Merlin-infected cells, using Benjamini-Hochberg corrected Significance B values (<xref ref-type="bibr" rid="bib8">Cox and Mann, 2008</xref>). Hierarchical clustering was performed using centroid linkage with Pearson correlation. The Database for Annotation, Visualization and Integrated Discovery (DAVID, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001881">SCR_001881</ext-link>) was used to determine protein family enrichment amongst KEGG pathways (<xref ref-type="bibr" rid="bib27">Huang et al., 2009</xref>). A given cluster was always searched against a background of all proteins quantified within the relevant experiment.</p><p>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (<xref ref-type="bibr" rid="bib53">Vizcaíno et al., 2014</xref>) via the PRIDE partner repository (<xref ref-type="bibr" rid="bib52">Vizcaíno et al., 2016</xref>) with the dataset identifier PXD005883.</p></sec><sec id="s4-8"><title>Flow cytometric analysis of cell surface marker expression</title><p>Flow cytometry was performed as described previously (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>), except HF-TERTs were harvested using HyQtase (Thermo Fisher Scientific, Paisley, UK) for 3 min at 37°C, instead of Trypsin/EDTA. The following phycoerytherin (PE)-conjugated antibodies were used at the indicated dilutions (200 µl per stain): anti-CD166/ALCAM (Biolegend, London, UK, Clone 3A6, Cat. no. 343904, 1:80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2289302">AB_2289302</ext-link>), anti-EPHA2 (Biolegend, Clone SHM16, Cat. no. 356804, 1:80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2561807">AB_2561807</ext-link>), anti-CD323/JAM3 (Biolegend, Clone SHM33, Cat. no. 356704, 1:80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2561802">AB_2561802</ext-link>), anti-CD130/IL6ST (Biolegend, Clone 2E1B02, Cat. no. 362003, 1:80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2563401">AB_2563401</ext-link>), IgG1 isotype (Biolegend, Clone MOPC-21, Cat. no. 400112, 1:80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_326434">AB_326434</ext-link>), mouse IgG2a isotype (Biolegend, Clone MOPC-173, Cat. no. 400212, 1:160, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_326460">AB_326460</ext-link>) and mouse IgG2b isotype (Biolegend, Clone MPC-11, Cat. no. 400314, 1:80, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_326492">AB_326492</ext-link>). The following unconjugated antibodies were used at the indicated dilutions (200 µl per stain): anti-CXADR/CAR (Merck Millipore, Cat no. 05–644, Clone RmcB, 1:500, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_309871">AB_309871</ext-link>), anti-CD266/TWEAK R/TNFRSF12A (Biolegend, Clone ITEM-4, Cat. no. 314102, 1:200, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2240752">AB_2240752</ext-link>), anti-MICA (BAMOMAB, Graefelfing, Germany, Cat. no. AM01, 1:400, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2636811">AB_2636811</ext-link>), anti-MICB (BAMOMAB, Cat. no. BM02, 1:400, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2636812">AB_2636812</ext-link>), anti-B7-H6 (Biotechne R and D Systems, Abingdon, UK, Clone 875001, Cat. no. MAB7144, 500 µg/ml, 1:50, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2636810">AB_2636810</ext-link>), anti-MHC I (BioRAd/AbD Serotec, Kidlington, UK, Clone W6/32, MCA81EL, 1:1000, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_324063">AB_324063</ext-link>) and mouse IgG (Santa Cruz Biotechnology, Heidelberg, Germany, Cat. no. Sc-2025, 400 µg/ml, 1:40, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_737182">AB_737182</ext-link> or Sigma Aldritch, Gillingham, UK, Cat. no. I-5381 1 mg/ml, 1:100, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1163670">AB_1163670</ext-link>), followed by an Alexa Fluor 647 goat anti-mouse IgG secondary antibody (Thermo Fisher Scientific, Cat. no. A21237, 1:500, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535806">AB_2535806</ext-link>).</p></sec><sec id="s4-9"><title>Immunoblotting</title><p>Whole cell lysates were prepared in 1x Nupage gel sample buffer (Thermo Fisher Scientific) plus 10 mM DTT and samples were denatured at 95°C or 50°C (US18 and US20 adenovirus experiment) for 10 mins. SDS-PAGE and subsequent immunoblotting was carried out as previously described either using X-ray film or a G:Box Chemix-xx6 GeneSys system (Syngene, Cambridge, UK) to visualise the blots (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>). Membranes were probed with antibodies directed against B7-H6 (non-commercial CH31 monoclonal, purified at 2 µg/ml final or hybridoma supernatant 1:5), anti-V5 antibody (BioRad/AbD Serotec, Cat. no. MCA1360, 1:2000, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_322378">AB_322378</ext-link>) and actin (Sigma Aldritch, Cat. no A2066, 1:5000, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_476693">AB_476693</ext-link>), followed by HRP-conjugated goat anti-mouse or anti-rabbit antibodies (BioRad/Ab Serotec, Cat. no. 170–6516, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11125547">AB_11125547</ext-link> and 170–6515, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_11125142">AB_11125142</ext-link> respectively, both 1:5000).</p></sec><sec id="s4-10"><title>NK degranulation assays</title><p>NK degranulation assays were performed as described previously using anti-CD107a-FITC (Cat. no. 555800, BD Biosciences, Oxford, UK, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396134">AB_396134</ext-link>) or isotype control-FITC (Cat no. 555748, BD Biosciences, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_396090">AB_396090</ext-link>) and anti-CD3-PE-Cy7 (Cat. no. 737657, Beckman Coulter, High Wycombe, UK RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2636813">AB_2636813</ext-link>) and anti-CD56-PE (Cat. no. A07788, Beckman Coulter, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2636814">AB_2636814</ext-link>) antibodies and PBMC derived from buffy coats or donor blood, except that infected HF-TERTs were harvested using HyQtase for 3 min at 37°C, instead of Trypsin/EDTA (<xref ref-type="bibr" rid="bib40">Prod'homme et al., 2007</xref>, <xref ref-type="bibr" rid="bib41">2010</xref>; <xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>). Blocking experiments were performed as previously described except using B7-H6 blocking antibody (CH31) or isotype IgG1 control antibody at 10 µg/ml (Biolegend, Cat. no. 401404, Clone MG1-45, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_345426">AB_345426</ext-link> or Biolegend, Cat no. 401402 Clone MG1-45, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_345424">AB_345424</ext-link>) (<xref ref-type="bibr" rid="bib19">Fielding et al., 2014</xref>).</p></sec><sec id="s4-11"><title>NKp30 reporter assays</title><p>HF-TERTs were seeded into 96-well plates and either mock-infected or infected with HCMV or US12 family deletion mutants (MOI 10) for 72 hr. The CT299 reporter line (2B4 cells stably transfected with an NFAT-GFP reporter and NKp30) was washed in complete RPMI and 50,000 reporter cells added per well (5:1 ratio of reporter to target cells). In some experiments, the B7-H6 blocking antibody (CH31) or isotype IgG1 control antibody (Biolegend, Cat. no. 401404, Clone MG1-45, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_345426">AB_345426</ext-link> or Biolegend Cat no. 401402 Clone MG1-45, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_345424">AB_345424</ext-link>) at 10 µg/ml were also added to the wells. After 24 hr incubation, reporters were harvested, washed in FACS buffer and fixed with 2% paraformaldehyde before analysis by flow cytometry.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This work was supported by funds from the Wellcome Trust WT090323MA and MRC G1000236. MR/L018373/1. This work was also supported by a Wellcome Trust Principal Research Fellowship (WT101835) to PJL and a Wellcome Trust Senior Fellowship (108070/Z/15/Z) to MPW and a strategic award to Cambridge Institute for Medical Research from the Wellcome Trust (100140). JAP was supported by NIH/NIDDK grant K01 DK098285. BV was supported by projects MEYS – NPS I – LO1413 and Czech Science Foundation P206/12/G151. ER was supported by MH CZ-DRO (MMCI, 00209805). CC and JT were supported by grant G0901682 from the MRC and funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 695551), with partial funding from the National Institute of Health Cambridge Biomedical Research Centre. The authors are grateful to Dawn Roberts for technical support and to blood donors who contributed to the study.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>CAF, Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>MPW, Conceptualization, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>LVN, Resources, Data curation, Software, Formal analysis, Visualization, Writing—original draft</p></fn><fn fn-type="con" id="con4"><p>ER, Resources, Methodology</p></fn><fn fn-type="con" id="con5"><p>GSW, Data curation, Formal analysis, Validation, Writing—original draft</p></fn><fn fn-type="con" id="con6"><p>JAP, Resources, Data curation, Software, Formal analysis</p></fn><fn fn-type="con" id="con7"><p>CC, Resources, Methodology</p></fn><fn fn-type="con" id="con8"><p>NMS, Data curation, Software, Formal analysis, Validation, Writing—original draft</p></fn><fn fn-type="con" id="con9"><p>JAD, Resources, Investigation</p></fn><fn fn-type="con" id="con10"><p>RA, Data curation, Investigation</p></fn><fn fn-type="con" id="con11"><p>RJS, Resources, Methodology</p></fn><fn fn-type="con" id="con12"><p>RJA, Resources, Methodology</p></fn><fn fn-type="con" id="con13"><p>HN, Resources, Investigation</p></fn><fn fn-type="con" id="con14"><p>BV, Resources, Methodology</p></fn><fn fn-type="con" id="con15"><p>JT, Resources, Methodology</p></fn><fn fn-type="con" id="con16"><p>AJD, Resources, Data curation, Software, Formal analysis, Methodology, Writing—original draft</p></fn><fn fn-type="con" id="con17"><p>SPG, Resources, Data curation, Software, Formal analysis, Methodology</p></fn><fn fn-type="con" id="con18"><p>PT, Conceptualization, Supervision, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con19"><p>PJL, Conceptualization, Resources, Data curation, Software, Supervision, Writing—original draft, Project administration, Writing—review and editing</p></fn><fn fn-type="con" id="con20"><p>GWGW, Conceptualization, Supervision, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Healthy adult volunteers provided blood for this study following written informed consent (approved by the Cardiff University School of Medicine Ethics Committee Ref. no: 10/20) or buffy coats provided by the Welsh Blood Service, following informed consent.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="SD1-data"><object-id pub-id-type="doi">10.7554/eLife.22206.019</object-id><label>Supplementary file 1.</label><caption><title>Interactive spreadsheet of all US12 family proteomic data (separate Excel Spreadsheet).</title><p>This spreadsheet enables the generation of graphs showing the relative expression of any of the human and HCMV proteins quantified across Proteomic series 1–3 in PM and WCL fractions by typing the gene name into the indicated box. The datasets used to generate the graph and protein aliases are present in the other tabs.</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.22206.019">http://dx.doi.org/10.7554/eLife.22206.019</ext-link></p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-22206-supp1-v3.xlsx"/></supplementary-material><sec id="s7" sec-type="datasets"><title>Major datasets</title><p>The following dataset was generated:</p><p><related-object content-type="generated-dataset" id="data-ro1" source-id="http://www.ebi.ac.uk/pride/archive/projects/PXD005883" source-id-type="uri"><collab>Michael P Weekes</collab><x>,</x> <year>2017</year><x>,</x><source>Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation</source><x>,</x> <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/pride/archive/projects/PXD005883">http://www.ebi.ac.uk/pride/archive/projects/PXD005883</ext-link><x>,</x> <comment>Publicly available at the PRIDE archive (accession no. PXD005883)</comment></related-object></p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandt</surname><given-names>CS</given-names></name><name><surname>Baratin</surname><given-names>M</given-names></name><name><surname>Yi</surname><given-names>EC</given-names></name><name><surname>Kennedy</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Fox</surname><given-names>B</given-names></name><name><surname>Haldeman</surname><given-names>B</given-names></name><name><surname>Ostrander</surname><given-names>CD</given-names></name><name><surname>Kaifu</surname><given-names>T</given-names></name><name><surname>Chabannon</surname><given-names>C</given-names></name><name><surname>Moretta</surname><given-names>A</given-names></name><name><surname>West</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name><name><surname>Levin</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans</article-title><source>The Journal of Experimental Medicine</source><volume>206</volume><fpage>1495</fpage><lpage>1503</lpage><pub-id pub-id-type="doi">10.1084/jem.20090681</pub-id><pub-id pub-id-type="pmid">19528259</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bronzini</surname><given-names>M</given-names></name><name><surname>Luganini</surname><given-names>A</given-names></name><name><surname>Dell'Oste</surname><given-names>V</given-names></name><name><surname>De Andrea</surname><given-names>M</given-names></name><name><surname>Landolfo</surname><given-names>S</given-names></name><name><surname>Gribaudo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The US16 gene of human Cytomegalovirus is required for efficient viral infection of endothelial and epithelial cells</article-title><source>Journal of Virology</source><volume>86</volume><fpage>6875</fpage><lpage>6888</lpage><pub-id pub-id-type="doi">10.1128/JVI.06310-11</pub-id><pub-id pub-id-type="pmid">22496217</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrara</surname><given-names>G</given-names></name><name><surname>Saraiva</surname><given-names>N</given-names></name><name><surname>Gubser</surname><given-names>C</given-names></name><name><surname>Johnson</surname><given-names>BF</given-names></name><name><surname>Smith</surname><given-names>GL</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Six-transmembrane topology for golgi anti-apoptotic protein (GAAP) and bax inhibitor 1 (BI-1) provides model for the transmembrane bax inhibitor-containing motif (TMBIM) family</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>15896</fpage><lpage>15905</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.336149</pub-id><pub-id pub-id-type="pmid">22418439</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaletto</surname><given-names>N</given-names></name><name><surname>Luganini</surname><given-names>A</given-names></name><name><surname>Gribaudo</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Inactivation of the human Cytomegalovirus US20 gene hampers productive viral replication in endothelial cells</article-title><source>Journal of Virology</source><volume>89</volume><fpage>11092</fpage><lpage>11106</lpage><pub-id pub-id-type="doi">10.1128/JVI.01141-15</pub-id><pub-id pub-id-type="pmid">26311874</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chee</surname><given-names>MS</given-names></name><name><surname>Bankier</surname><given-names>AT</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name><name><surname>Bohni</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>CM</given-names></name><name><surname>Cerny</surname><given-names>R</given-names></name><name><surname>Horsnell</surname><given-names>T</given-names></name><name><surname>Hutchison</surname><given-names>CA</given-names></name><name><surname>Kouzarides</surname><given-names>T</given-names></name><name><surname>Martignetti</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Analysis of the protein-coding content of the sequence of human Cytomegalovirus strain AD169</article-title><source>Current Topics in Microbiology and Immunology</source><volume>154</volume><fpage>125</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1007/978-3-642-74980-3_6</pub-id><pub-id pub-id-type="pmid">2161319</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correia</surname><given-names>DV</given-names></name><name><surname>Fogli</surname><given-names>M</given-names></name><name><surname>Hudspeth</surname><given-names>K</given-names></name><name><surname>da Silva</surname><given-names>MG</given-names></name><name><surname>Mavilio</surname><given-names>D</given-names></name><name><surname>Silva-Santos</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Differentiation of human peripheral blood vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells</article-title><source>Blood</source><volume>118</volume><fpage>992</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1182/blood-2011-02-339135</pub-id><pub-id pub-id-type="pmid">21633088</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa-Pereira</surname><given-names>AP</given-names></name><name><surname>Tininini</surname><given-names>S</given-names></name><name><surname>Strobl</surname><given-names>B</given-names></name><name><surname>Alonzi</surname><given-names>T</given-names></name><name><surname>Schlaak</surname><given-names>JF</given-names></name><name><surname>Is'harc</surname><given-names>H</given-names></name><name><surname>Gesualdo</surname><given-names>I</given-names></name><name><surname>Newman</surname><given-names>SJ</given-names></name><name><surname>Kerr</surname><given-names>IM</given-names></name><name><surname>Poli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Mutational switch of an IL-6 response to an interferon-gamma-like response</article-title><source>PNAS</source><volume>99</volume><fpage>8043</fpage><lpage>8047</lpage><pub-id pub-id-type="doi">10.1073/pnas.122236099</pub-id><pub-id pub-id-type="pmid">12060750</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification</article-title><source>Nature Biotechnology</source><volume>26</volume><fpage>1367</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1038/nbt.1511</pub-id><pub-id pub-id-type="pmid">19029910</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Matic</surname><given-names>I</given-names></name><name><surname>Hilger</surname><given-names>M</given-names></name><name><surname>Nagaraj</surname><given-names>N</given-names></name><name><surname>Selbach</surname><given-names>M</given-names></name><name><surname>Olsen</surname><given-names>JV</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A practical guide to the MaxQuant computational platform for SILAC‐based quantitative proteomics</article-title><source>Nature Protocols</source><volume>4</volume><fpage>698</fpage><lpage>705.</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.36</pub-id><pub-id pub-id-type="pmid">19373234</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Croft</surname><given-names>M</given-names></name><name><surname>Benedict</surname><given-names>CA</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Clinical targeting of the TNF and TNFR superfamilies</article-title><source>Nature Reviews Drug Discovery</source><volume>12</volume><fpage>147</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1038/nrd3930</pub-id><pub-id pub-id-type="pmid">23334208</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Pellett</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Members of the HCMV US12 family of predicted heptaspanning membrane proteins have unique intracellular distributions, including association with the cytoplasmic virion assembly complex</article-title><source>Virology</source><volume>361</volume><fpage>263</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2006.11.019</pub-id><pub-id pub-id-type="pmid">17188320</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>Stow</surname><given-names>ND</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Fundamental and accessory systems in herpesviruses</article-title><source>Antiviral Research</source><volume>56</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(02)00107-9</pub-id><pub-id pub-id-type="pmid">12323395</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Dolan</surname><given-names>A</given-names></name><name><surname>Akter</surname><given-names>P</given-names></name><name><surname>Addison</surname><given-names>C</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>Alcendor</surname><given-names>DJ</given-names></name><name><surname>McGeoch</surname><given-names>DJ</given-names></name><name><surname>Hayward</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The human Cytomegalovirus genome revisited: comparison with the chimpanzee Cytomegalovirus genome</article-title><source>Journal of General Virology</source><volume>84</volume><fpage>17</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1099/vir.0.18606-0</pub-id><pub-id pub-id-type="pmid">12533697</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Holton</surname><given-names>M</given-names></name><name><surname>Dolan</surname><given-names>A</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>Gatherer</surname><given-names>D</given-names></name><name><surname>Hayward</surname><given-names>GS</given-names></name></person-group><year iso-8601-date="2013">2013</year><chapter-title>Comparitive genomics of primate cytomegaloviruses</chapter-title><person-group person-group-type="editor"><name><surname>Reddehase</surname> <given-names>M. J</given-names></name></person-group><source>Cytomegaloviruses: From Molecular Pathogenesis to Intervention</source><publisher-loc>Norwich, UK</publisher-loc><publisher-name>Caister Academic Press</publisher-name><fpage>1906</fpage></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dennis</surname><given-names>G</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Hosack</surname><given-names>DA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>DAVID: database for annotation, visualization, and integrated discovery</article-title><source>Genome Biology</source><volume>4</volume><elocation-id>60</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2003-4-9-r60</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolan</surname><given-names>A</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name><name><surname>Hector</surname><given-names>RD</given-names></name><name><surname>Hassan-Walker</surname><given-names>AF</given-names></name><name><surname>Lee</surname><given-names>L</given-names></name><name><surname>Addison</surname><given-names>C</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>McGeoch</surname><given-names>DJ</given-names></name><name><surname>Gatherer</surname><given-names>D</given-names></name><name><surname>Emery</surname><given-names>VC</given-names></name><name><surname>Griffiths</surname><given-names>PD</given-names></name><name><surname>Sinzger</surname><given-names>C</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Genetic content of wild-type human Cytomegalovirus</article-title><source>Journal of General Virology</source><volume>85</volume><fpage>1301</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1099/vir.0.79888-0</pub-id><pub-id pub-id-type="pmid">15105547</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>W</given-names></name><name><surname>Chou</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Hai</surname><given-names>R</given-names></name><name><surname>Patterson</surname><given-names>D</given-names></name><name><surname>Stolc</surname><given-names>V</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Functional profiling of a human Cytomegalovirus genome</article-title><source>PNAS</source><volume>100</volume><fpage>14223</fpage><lpage>14228</lpage><pub-id pub-id-type="doi">10.1073/pnas.2334032100</pub-id><pub-id pub-id-type="pmid">14623981</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elde</surname><given-names>NC</given-names></name><name><surname>Child</surname><given-names>SJ</given-names></name><name><surname>Eickbush</surname><given-names>MT</given-names></name><name><surname>Kitzman</surname><given-names>JO</given-names></name><name><surname>Rogers</surname><given-names>KS</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name><name><surname>Geballe</surname><given-names>AP</given-names></name><name><surname>Malik</surname><given-names>HS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Poxviruses deploy genomic accordions to adapt rapidly against host antiviral defenses</article-title><source>Cell</source><volume>150</volume><fpage>831</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2012.05.049</pub-id><pub-id pub-id-type="pmid">22901812</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fielding</surname><given-names>CA</given-names></name><name><surname>Aicheler</surname><given-names>R</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Seirafian</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>J</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Antrobus</surname><given-names>PR</given-names></name><name><surname>Prod'homme</surname><given-names>V</given-names></name><name><surname>Blanchet</surname><given-names>FP</given-names></name><name><surname>Sugrue</surname><given-names>D</given-names></name><name><surname>Cuff</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>D</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Two novel human Cytomegalovirus NK cell evasion functions target MICA for lysosomal degradation</article-title><source>PLoS Pathogens</source><volume>10</volume><elocation-id>e1004058</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004058</pub-id><pub-id pub-id-type="pmid">24787765</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filée</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Route of NCLDV evolution: the genomic accordion</article-title><source>Current Opinion in Virology</source><volume>3</volume><fpage>595</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1016/j.coviro.2013.07.003</pub-id><pub-id pub-id-type="pmid">23896278</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurczynski</surname><given-names>SJ</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Pellett</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Deletion of the human Cytomegalovirus US17 gene increases the ratio of genomes per infectious unit and alters regulation of immune and endoplasmic reticulum stress response genes at early and late times after infection</article-title><source>Journal of Virology</source><volume>88</volume><fpage>2168</fpage><lpage>2182</lpage><pub-id pub-id-type="doi">10.1128/JVI.02704-13</pub-id><pub-id pub-id-type="pmid">24335296</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hai</surname><given-names>R</given-names></name><name><surname>Chu</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Umamoto</surname><given-names>S</given-names></name><name><surname>Rider</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Infection of human Cytomegalovirus in cultured human gingival tissue</article-title><source>Virology Journal</source><volume>3</volume><elocation-id>84</elocation-id><pub-id pub-id-type="doi">10.1186/1743-422X-3-84</pub-id><pub-id pub-id-type="pmid">17022821</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harwardt</surname><given-names>T</given-names></name><name><surname>Lukas</surname><given-names>S</given-names></name><name><surname>Zenger</surname><given-names>M</given-names></name><name><surname>Reitberger</surname><given-names>T</given-names></name><name><surname>Danzer</surname><given-names>D</given-names></name><name><surname>Übner</surname><given-names>T</given-names></name><name><surname>Munday</surname><given-names>DC</given-names></name><name><surname>Nevels</surname><given-names>M</given-names></name><name><surname>Paulus</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Human Cytomegalovirus Immediate-Early 1 protein rewires upstream STAT3 to downstream STAT1 signaling switching an IL6-Type to an IFNγ-Like response</article-title><source>PLoS Pathogens</source><volume>12</volume><elocation-id>e1005748</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1005748</pub-id><pub-id pub-id-type="pmid">27387064</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>NJ</given-names></name><name><surname>Barclay</surname><given-names>AN</given-names></name><name><surname>Brown</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Frontline: optimal T cell activation requires the engagement of CD6 and CD166</article-title><source>European Journal of Immunology</source><volume>34</volume><fpage>930</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1002/eji.200424856</pub-id><pub-id pub-id-type="pmid">15048703</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holzerlandt</surname><given-names>R</given-names></name><name><surname>Orengo</surname><given-names>C</given-names></name><name><surname>Kellam</surname><given-names>P</given-names></name><name><surname>Albà</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Identification of new herpesvirus gene homologs in the human genome</article-title><source>Genome Research</source><volume>12</volume><fpage>1739</fpage><lpage>1748</lpage><pub-id pub-id-type="doi">10.1101/gr.334302</pub-id><pub-id pub-id-type="pmid">12421761</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>JL</given-names></name><name><surname>van den Boomen</surname><given-names>DJ</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Antrobus</surname><given-names>R</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Ruckova</surname><given-names>E</given-names></name><name><surname>Sugrue</surname><given-names>D</given-names></name><name><surname>Wilkie</surname><given-names>GS</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141</article-title><source>PLoS Pathogens</source><volume>11</volume><elocation-id>e1004811</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004811</pub-id><pub-id pub-id-type="pmid">25875600</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>daW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huttlin</surname><given-names>EL</given-names></name><name><surname>Jedrychowski</surname><given-names>MP</given-names></name><name><surname>Elias</surname><given-names>JE</given-names></name><name><surname>Goswami</surname><given-names>T</given-names></name><name><surname>Rad</surname><given-names>R</given-names></name><name><surname>Beausoleil</surname><given-names>SA</given-names></name><name><surname>Villén</surname><given-names>J</given-names></name><name><surname>Haas</surname><given-names>W</given-names></name><name><surname>Sowa</surname><given-names>ME</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A tissue-specific atlas of mouse protein phosphorylation and expression</article-title><source>Cell</source><volume>143</volume><fpage>1174</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2010.12.001</pub-id><pub-id pub-id-type="pmid">21183079</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanneganti</surname><given-names>TD</given-names></name><name><surname>Lamkanfi</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>YG</given-names></name><name><surname>Chen</surname><given-names>G</given-names></name><name><surname>Park</surname><given-names>JH</given-names></name><name><surname>Franchi</surname><given-names>L</given-names></name><name><surname>Vandenabeele</surname><given-names>P</given-names></name><name><surname>Núñez</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling</article-title><source>Immunity</source><volume>26</volume><fpage>433</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2007.03.008</pub-id><pub-id pub-id-type="pmid">17433728</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafarge</surname><given-names>X</given-names></name><name><surname>Merville</surname><given-names>P</given-names></name><name><surname>Cazin</surname><given-names>MC</given-names></name><name><surname>Bergé</surname><given-names>F</given-names></name><name><surname>Potaux</surname><given-names>L</given-names></name><name><surname>Moreau</surname><given-names>JF</given-names></name><name><surname>Déchanet-Merville</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role</article-title><source>The Journal of Infectious Diseases</source><volume>184</volume><fpage>533</fpage><lpage>541</lpage><pub-id pub-id-type="doi">10.1086/322843</pub-id><pub-id pub-id-type="pmid">11494158</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>GH</given-names></name><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Chae</surname><given-names>HJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Bax inhibitor-1 regulates the expression of P450 2E1 through enhanced lysosome activity</article-title><source>The International Journal of Biochemistry &amp; Cell Biology</source><volume>44</volume><fpage>600</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2011.12.017</pub-id><pub-id pub-id-type="pmid">22230367</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesniewski</surname><given-names>M</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Skomorovska-Prokvolit</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>FZ</given-names></name><name><surname>Pellett</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Primate Cytomegalovirus US12 gene family: a distinct and diverse clade of seven-transmembrane proteins</article-title><source>Virology</source><volume>354</volume><fpage>286</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2006.06.035</pub-id><pub-id pub-id-type="pmid">16904149</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matta</surname><given-names>J</given-names></name><name><surname>Baratin</surname><given-names>M</given-names></name><name><surname>Chiche</surname><given-names>L</given-names></name><name><surname>Forel</surname><given-names>JM</given-names></name><name><surname>Cognet</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Farnarier</surname><given-names>C</given-names></name><name><surname>Piperoglou</surname><given-names>C</given-names></name><name><surname>Papazian</surname><given-names>L</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>Ugolini</surname><given-names>S</given-names></name><name><surname>Vély</surname><given-names>F</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions</article-title><source>Blood</source><volume>122</volume><fpage>394</fpage><lpage>404</lpage><pub-id pub-id-type="doi">10.1182/blood-2013-01-481705</pub-id><pub-id pub-id-type="pmid">23687088</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McAlister</surname><given-names>GC</given-names></name><name><surname>Russell</surname><given-names>JD</given-names></name><name><surname>Rumachik</surname><given-names>NG</given-names></name><name><surname>Hebert</surname><given-names>AS</given-names></name><name><surname>Syka</surname><given-names>JE</given-names></name><name><surname>Geer</surname><given-names>LY</given-names></name><name><surname>Westphall</surname><given-names>MS</given-names></name><name><surname>Pagliarini</surname><given-names>DJ</given-names></name><name><surname>Coon</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Analysis of the acidic proteome with negative electron-transfer dissociation mass spectrometry</article-title><source>Analytical Chemistry</source><volume>84</volume><fpage>2875</fpage><lpage>2882</lpage><pub-id pub-id-type="doi">10.1021/ac203430u</pub-id><pub-id pub-id-type="pmid">22335612</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Jones</surname><given-names>CJ</given-names></name><name><surname>Skinner</surname><given-names>JW</given-names></name><name><surname>Kipling</surname><given-names>D</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human Cytomegalovirus</article-title><source>Journal of General Virology</source><volume>82</volume><fpage>855</fpage><lpage>863</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-82-4-855</pub-id><pub-id pub-id-type="pmid">11257191</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merville</surname><given-names>P</given-names></name><name><surname>Déchanet</surname><given-names>J</given-names></name><name><surname>Bergé</surname><given-names>F</given-names></name><name><surname>Bone-Mane</surname><given-names>G</given-names></name><name><surname>Taupin</surname><given-names>J</given-names></name><name><surname>Michel</surname><given-names>P</given-names></name><name><surname>Joly</surname><given-names>P</given-names></name><name><surname>Bonneville</surname><given-names>M</given-names></name><name><surname>Potaux</surname><given-names>L</given-names></name><name><surname>Moreau</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cytomegalovirus infection in kidney allograft recipients is followed by a prolonged expansion of gammadelta T lymphocytes</article-title><source>Transplantation Proceedings</source><volume>32</volume><fpage>357</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1016/S0041-1345(99)00978-1</pub-id><pub-id pub-id-type="pmid">10715438</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murrell</surname><given-names>I</given-names></name><name><surname>Wilkie</surname><given-names>GS</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Statkute</surname><given-names>E</given-names></name><name><surname>Fielding</surname><given-names>CA</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic stability of bacterial artificial Chromosome-Derived human Cytomegalovirus during culture in vitro</article-title><source>Journal of Virology</source><volume>90</volume><fpage>3929</fpage><lpage>3943</lpage><pub-id pub-id-type="doi">10.1128/JVI.02858-15</pub-id><pub-id pub-id-type="pmid">26842472</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Svetkauskaite</surname><given-names>D</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Strassheim</surname><given-names>D</given-names></name><name><surname>Ishizaka</surname><given-names>A</given-names></name><name><surname>Abraham</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>7370</fpage><lpage>7377</lpage><pub-id pub-id-type="doi">10.1074/jbc.M306793200</pub-id><pub-id pub-id-type="pmid">14660645</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pease</surname><given-names>BN</given-names></name><name><surname>Huttlin</surname><given-names>EL</given-names></name><name><surname>Jedrychowski</surname><given-names>MP</given-names></name><name><surname>Talevich</surname><given-names>E</given-names></name><name><surname>Harmon</surname><given-names>J</given-names></name><name><surname>Dillman</surname><given-names>T</given-names></name><name><surname>Kannan</surname><given-names>N</given-names></name><name><surname>Doerig</surname><given-names>C</given-names></name><name><surname>Chakrabarti</surname><given-names>R</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Chakrabarti</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Global analysis of protein expression and phosphorylation of three stages of plasmodium falciparum intraerythrocytic development</article-title><source>Journal of Proteome Research</source><volume>12</volume><fpage>4028</fpage><lpage>4045</lpage><pub-id pub-id-type="doi">10.1021/pr400394g</pub-id><pub-id pub-id-type="pmid">23914800</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prod'homme</surname><given-names>V</given-names></name><name><surname>Griffin</surname><given-names>C</given-names></name><name><surname>Aicheler</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>ECY</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Rickards</surname><given-names>CR</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Borysiewicz</surname><given-names>LK</given-names></name><name><surname>Lopez-Botet</surname><given-names>M</given-names></name><name><surname>Wilkinson</surname><given-names>GWG</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The human Cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells</article-title><source>The Journal of Immunology</source><volume>178</volume><fpage>4473</fpage><lpage>4481</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.7.4473</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prod'homme</surname><given-names>V</given-names></name><name><surname>Sugrue</surname><given-names>DM</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Nomoto</surname><given-names>A</given-names></name><name><surname>Davies</surname><given-names>J</given-names></name><name><surname>Rickards</surname><given-names>CR</given-names></name><name><surname>Cochrane</surname><given-names>D</given-names></name><name><surname>Moore</surname><given-names>M</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Human Cytomegalovirus UL141 promotes efficient downregulation of the natural killer cell activating ligand CD112</article-title><source>Journal of General Virology</source><volume>91</volume><fpage>2034</fpage><lpage>2039</lpage><pub-id pub-id-type="doi">10.1099/vir.0.021931-0</pub-id><pub-id pub-id-type="pmid">20410314</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas-Rivera</surname><given-names>D</given-names></name><name><surname>Hetz</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>TMBIM protein family: ancestral regulators of cell death</article-title><source>Oncogene</source><volume>34</volume><fpage>269</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/onc.2014.6</pub-id><pub-id pub-id-type="pmid">24561528</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rolle</surname><given-names>A</given-names></name><name><surname>Mousavi-Jazi</surname><given-names>M</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Odeberg</surname><given-names>J</given-names></name><name><surname>Soderberg-Naucler</surname><given-names>C</given-names></name><name><surname>Cosman</surname><given-names>D</given-names></name><name><surname>Karre</surname><given-names>K</given-names></name><name><surname>Cerboni</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Effects of human Cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-Binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein</article-title><source>The Journal of Immunology</source><volume>171</volume><fpage>902</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.171.2.902</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sijmons</surname><given-names>S</given-names></name><name><surname>Thys</surname><given-names>K</given-names></name><name><surname>Mbong Ngwese</surname><given-names>M</given-names></name><name><surname>Van Damme</surname><given-names>E</given-names></name><name><surname>Dvorak</surname><given-names>J</given-names></name><name><surname>Van Loock</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Tachezy</surname><given-names>R</given-names></name><name><surname>Busson</surname><given-names>L</given-names></name><name><surname>Aerssens</surname><given-names>J</given-names></name><name><surname>Van Ranst</surname><given-names>M</given-names></name><name><surname>Maes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>High-throughput analysis of human Cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination</article-title><source>Journal of Virology</source><fpage>7673</fpage><lpage>7695</lpage><pub-id pub-id-type="doi">10.1128/JVI.00578-15</pub-id><pub-id pub-id-type="pmid">25972543</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>W</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Aicheler</surname><given-names>R</given-names></name><name><surname>Loewendorf</surname><given-names>A</given-names></name><name><surname>Nemčovičová</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Macauley</surname><given-names>M</given-names></name><name><surname>Norris</surname><given-names>P</given-names></name><name><surname>Willen</surname><given-names>L</given-names></name><name><surname>Ruckova</surname><given-names>E</given-names></name><name><surname>Nomoto</surname><given-names>A</given-names></name><name><surname>Schneider</surname><given-names>P</given-names></name><name><surname>Hahn</surname><given-names>G</given-names></name><name><surname>Zajonc</surname><given-names>DM</given-names></name><name><surname>Ware</surname><given-names>CF</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Benedict</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Human Cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses</article-title><source>Cell Host &amp; Microbe</source><volume>13</volume><fpage>324</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.02.003</pub-id><pub-id pub-id-type="pmid">23498957</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanton</surname><given-names>R</given-names></name><name><surname>McSharry</surname><given-names>B</given-names></name><name><surname>Armstrong</surname><given-names>M</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Wilkinson</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function</article-title><source>BioTechniques</source><volume>45</volume><fpage>659</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.2144/000112993</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Baluchova</surname><given-names>K</given-names></name><name><surname>Dargan</surname><given-names>DJ</given-names></name><name><surname>Cunningham</surname><given-names>C</given-names></name><name><surname>Sheehy</surname><given-names>O</given-names></name><name><surname>Seirafian</surname><given-names>S</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Neale</surname><given-names>ML</given-names></name><name><surname>Davies</surname><given-names>JA</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Reconstruction of the complete human Cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication</article-title><source>Journal of Clinical Investigation</source><volume>120</volume><fpage>3191</fpage><lpage>3208</lpage><pub-id pub-id-type="doi">10.1172/JCI42955</pub-id><pub-id pub-id-type="pmid">20679731</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stern-Ginossar</surname><given-names>N</given-names></name><name><surname>Weisburd</surname><given-names>B</given-names></name><name><surname>Michalski</surname><given-names>A</given-names></name><name><surname>Le</surname><given-names>VT</given-names></name><name><surname>Hein</surname><given-names>MY</given-names></name><name><surname>Huang</surname><given-names>SX</given-names></name><name><surname>Ma</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Qian</surname><given-names>SB</given-names></name><name><surname>Hengel</surname><given-names>H</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Ingolia</surname><given-names>NT</given-names></name><name><surname>Weissman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Decoding human cytomegalovirus</article-title><source>Science</source><volume>338</volume><fpage>1088</fpage><lpage>1093</lpage><pub-id pub-id-type="doi">10.1126/science.1227919</pub-id><pub-id pub-id-type="pmid">23180859</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timms</surname><given-names>RT</given-names></name><name><surname>Duncan</surname><given-names>LM</given-names></name><name><surname>Tchasovnikarova</surname><given-names>IA</given-names></name><name><surname>Antrobus</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Dougan</surname><given-names>G</given-names></name><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases</article-title><source>PLoS Pathogens</source><volume>9</volume><elocation-id>e1003772</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003772</pub-id><pub-id pub-id-type="pmid">24278019</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname><given-names>L</given-names></name><name><surname>Rad</surname><given-names>R</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Haas</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics</article-title><source>Nature Methods</source><volume>8</volume><fpage>937</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1714</pub-id><pub-id pub-id-type="pmid">21963607</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>Davison</surname><given-names>AJ</given-names></name><name><surname>Vojtesek</surname><given-names>B</given-names></name><name><surname>Armstrong</surname><given-names>M</given-names></name><name><surname>Griffin</surname><given-names>C</given-names></name><name><surname>McSharry</surname><given-names>BP</given-names></name><name><surname>Morris</surname><given-names>RJ</given-names></name><name><surname>Llewellyn-Lacey</surname><given-names>S</given-names></name><name><surname>Rickards</surname><given-names>C</given-names></name><name><surname>Nomoto</surname><given-names>A</given-names></name><name><surname>Sinzger</surname><given-names>C</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Downregulation of natural killer cell-activating ligand CD155 by human Cytomegalovirus UL141</article-title><source>Nature Immunology</source><volume>6</volume><fpage>181</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1038/ni1156</pub-id><pub-id pub-id-type="pmid">15640804</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizcaíno</surname><given-names>JA</given-names></name><name><surname>Csordas</surname><given-names>A</given-names></name><name><surname>del-Toro</surname><given-names>N</given-names></name><name><surname>Dianes</surname><given-names>JA</given-names></name><name><surname>Griss</surname><given-names>J</given-names></name><name><surname>Lavidas</surname><given-names>I</given-names></name><name><surname>Mayer</surname><given-names>G</given-names></name><name><surname>Perez-Riverol</surname><given-names>Y</given-names></name><name><surname>Reisinger</surname><given-names>F</given-names></name><name><surname>Ternent</surname><given-names>T</given-names></name><name><surname>Xu</surname><given-names>QW</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Hermjakob</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>2016 update of the PRIDE database and its related tools</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D447</fpage><lpage>D456</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1145</pub-id><pub-id pub-id-type="pmid">26527722</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vizcaíno</surname><given-names>JA</given-names></name><name><surname>Deutsch</surname><given-names>EW</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Csordas</surname><given-names>A</given-names></name><name><surname>Reisinger</surname><given-names>F</given-names></name><name><surname>Ríos</surname><given-names>D</given-names></name><name><surname>Dianes</surname><given-names>JA</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Farrah</surname><given-names>T</given-names></name><name><surname>Bandeira</surname><given-names>N</given-names></name><name><surname>Binz</surname><given-names>PA</given-names></name><name><surname>Xenarios</surname><given-names>I</given-names></name><name><surname>Eisenacher</surname><given-names>M</given-names></name><name><surname>Mayer</surname><given-names>G</given-names></name><name><surname>Gatto</surname><given-names>L</given-names></name><name><surname>Campos</surname><given-names>A</given-names></name><name><surname>Chalkley</surname><given-names>RJ</given-names></name><name><surname>Kraus</surname><given-names>HJ</given-names></name><name><surname>Albar</surname><given-names>JP</given-names></name><name><surname>Martinez-Bartolomé</surname><given-names>S</given-names></name><name><surname>Apweiler</surname><given-names>R</given-names></name><name><surname>Omenn</surname><given-names>GS</given-names></name><name><surname>Martens</surname><given-names>L</given-names></name><name><surname>Jones</surname><given-names>AR</given-names></name><name><surname>Hermjakob</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ProteomeXchange provides globally coordinated proteomics data submission and dissemination</article-title><source>Nature Biotechnology</source><volume>32</volume><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/nbt.2839</pub-id><pub-id pub-id-type="pmid">24727771</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Chapoval</surname><given-names>AI</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name><name><surname>Tamada</surname><given-names>K</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS</article-title><source>Blood</source><volume>96</volume><fpage>2808</fpage><lpage>2813</lpage><pub-id pub-id-type="pmid">11023515</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Tan</surname><given-names>SY</given-names></name><name><surname>Poole</surname><given-names>E</given-names></name><name><surname>Talbot</surname><given-names>S</given-names></name><name><surname>Antrobus</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>DL</given-names></name><name><surname>Montag</surname><given-names>C</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name><name><surname>Sinclair</surname><given-names>JH</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Latency-associated degradation of the MRP1 drug transporter during latent human Cytomegalovirus infection</article-title><source>Science</source><volume>340</volume><fpage>199</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1126/science.1235047</pub-id><pub-id pub-id-type="pmid">23580527</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weekes</surname><given-names>MP</given-names></name><name><surname>Tomasec</surname><given-names>P</given-names></name><name><surname>Huttlin</surname><given-names>EL</given-names></name><name><surname>Fielding</surname><given-names>CA</given-names></name><name><surname>Nusinow</surname><given-names>D</given-names></name><name><surname>Stanton</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>EC</given-names></name><name><surname>Aicheler</surname><given-names>R</given-names></name><name><surname>Murrell</surname><given-names>I</given-names></name><name><surname>Wilkinson</surname><given-names>GW</given-names></name><name><surname>Lehner</surname><given-names>PJ</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Quantitative temporal viromics: an approach to investigate host-pathogen interaction</article-title><source>Cell</source><volume>157</volume><fpage>1460</fpage><lpage>1472</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.04.028</pub-id><pub-id pub-id-type="pmid">24906157</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>GWG</given-names></name><name><surname>Aicheler</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>ECY</given-names></name></person-group><year iso-8601-date="2013">2013</year><chapter-title>Natural Killer Cells and Human Cytomegalovirus</chapter-title><person-group person-group-type="editor"><name><surname>Reddehase</surname> <given-names>M</given-names></name></person-group><source>Cytomegaloviruses: From Molecular Pathogenesis to Intervention</source><publisher-name>Caister Academic Press</publisher-name><fpage>172</fpage><lpage>190</lpage></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witherden</surname><given-names>DA</given-names></name><name><surname>Verdino</surname><given-names>P</given-names></name><name><surname>Rieder</surname><given-names>SE</given-names></name><name><surname>Garijo</surname><given-names>O</given-names></name><name><surname>Mills</surname><given-names>RE</given-names></name><name><surname>Teyton</surname><given-names>L</given-names></name><name><surname>Fischer</surname><given-names>WH</given-names></name><name><surname>Wilson</surname><given-names>IA</given-names></name><name><surname>Havran</surname><given-names>WL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation</article-title><source>Science</source><volume>329</volume><fpage>1205</fpage><lpage>1210</lpage><pub-id pub-id-type="doi">10.1126/science.1192698</pub-id><pub-id pub-id-type="pmid">20813954</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaji</surname><given-names>T</given-names></name><name><surname>Nishikawa</surname><given-names>K</given-names></name><name><surname>Hanada</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis</article-title><source>Journal of Biological Chemistry</source><volume>285</volume><fpage>35505</fpage><lpage>35518</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.154229</pub-id><pub-id pub-id-type="pmid">20837469</pub-id></element-citation></ref></ref-list></back><sub-article article-type="article-commentary" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.22206.022</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yokoyama</surname><given-names>Wayne M</given-names></name><role>Reviewing editor</role><aff id="aff8"><institution>Howard Hughes Medical Institute, Washington University School of Medicine</institution>, <country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Control of immune ligands by members of a cytomegalovirus gene expansion suppresses natural killer cell activation&quot; for consideration by <italic>eLife</italic>. Your article has been favorably evaluated by Wenhui Li (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The following individual involved in review of your submission has agreed to reveal his identity: Michael G Brown (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>Human cytomegalovirus (HCMV) devotes a significant portion of its dsDNA genome to produce molecules that improve &quot;viral fitness,&quot; most often resulting in immune evasion. Here Fielding et al. focus on a region of the HCMV genome, termed US21 family (US12-US21). They took a comprehensive mass spectrometry approach to determine which molecules are affected by deleting these viral genes, using single and complete US21 family knockout viruses. The data strongly support the overall conclusion that these molecules affect NK cell activation against virus-infected cells. That the US21 family affects NKG2D ligands is not surprising but they also demonstrate nicely that US18 and US20 affect expression of B7-H6, that is induced upon viral infection with mutants lacking either one of these ORFs. Overall, the manuscript was favorably viewed but the reviewers felt that a number of issues need to be addressed.</p><p>Essential revisions:</p><p>While the comments of the reviewers are attached and should be addressed, the reviewers request that the authors specifically address the following major points in a revision.</p><p>1) The regulation of B7-H6 by ectopic expression of US18 and/or US20. See reviewers #1 and #3.</p><p>2) Explicit demonstration that US20 effect on MIC-A is impacted by US21. This is mentioned as data not shown but the reviewers would like the authors to show the data. See reviewer #3.</p><p>3) The% infected cells should be included in each of the figure legends. See reviewer #3.</p><p>4) The statistical analysis of the experiments. See reviewer #2.</p><p><italic>Reviewer #1:</italic> </p><p>It would be informative to express US18 and US20 individually or together by transfection and determine their effects on B7-H6 expression. This will help to confirm that the data with the individual ko viruses are not due to some other effect on the viral genome, such as an inadvertent deletion of an unrecognized ORF in the ko viruses.</p><p><xref ref-type="fig" rid="fig11">Figure 11</xref> shows upregulation of B7-H6 expression by control adenovirus infection, helping to make the case that viral infection induces B7-H6 expression. I don't believe this has been shown before, though there are some data indicating that B7-H6 is inducible (Blood 2013, 122:394). However, neither of these points was mentioned in the text which instead focused on the markedly higher levels of B7-H6 expression when the adenoviral vector contained B7-H6. It would be informative if the adenoviral vector contained US18, US20, or both to determine if B7-H6 expression is down-regulated only when both ORFs are ectopically expressed.</p><p>Finally, it would be of interest to determine if cells constitutively expressing high levels of B7-H6 are affected by US18/US20. If not, the ORFs may be affecting the mechanisms leading to viral induction of B7-H6, rather than B7-H6 itself.</p><p><italic>Reviewer #2:</italic> </p><p>Strengths of the study include its innovative approach, in depth analysis of US12 related genes and their broad effect on host immune responses/proteomes, and follow up analyses of specific protein effects (e.g. B7H6). The work is technically excellent, with results effectively presented. The color scheme used to present data for comparison of various HCMV strains, and their effect on many different host molecules has transformed what would appear to be very complex data sets, into ones that are both manageable and elegant. Having implicated specific US12-targeted effects on host proteins, and that these molecules have evolved tag-team strategies to thwart NK cells, is highly interesting. Overall, the findings and conclusions are openly presented, and very compelling. They should generate considerable interest. Although effective strategies and cutoffs were implemented to focus on findings of high significance, there is some question and lingering concern about the use of statistical tests applied, or not, in some experiments.</p><p>Main concern:</p><p>Multiple comparisons performed in <xref ref-type="fig" rid="fig1">Figure 1B</xref> using a student's t test may be inappropriate. Also, it appears that statistical analyses were not performed in <xref ref-type="fig" rid="fig4">Figures 4</xref>, <xref ref-type="fig" rid="fig5">5</xref>, <xref ref-type="fig" rid="fig7">7C</xref> and <xref ref-type="fig" rid="fig8">8</xref>. Why?</p><p><italic>Reviewer #3:</italic> </p><p>Interestingly, and somewhat of concern, deletion of US21 impacted the expression of many other viral genes, including US20 whereas this was not observed when the entire region US12-21 was deleted. The authors argue that this is likely due to the fact that the impact on US20 by US21 no longer occurs when both are deleted, but this is not explicitly shown. I suggest these data are included upon revision.</p><p>Interestingly, they find that deletion of US12, US13 and US20 upregulates UL16 as well deletion of US12-21. Since UL16 prevents the intracellular transport of multiple NKG2D-ligands this result could imply that some of the observed changes in NK cell molecules could be an indirect consequence of US12 family members promoting the expression or stabilization of UL16 which in turn could decrease the lysosomal turnover of target proteins by retaining them in the ER. The possibility that the effects seen are indirect consequences of US12 proteins regulating other viral proteins should be acknowledged more explicitly in the text and it should be clearly stated that this is one of the caveats of the current study.</p><p>The authors next focus on one protein in particular, B7-H6, a ligand for the NK cell activating receptor NKp30 that is also found on γδT cells. Using adenoviral expression they demonstrate that B7-H6 activates NK cells. Furthermore, a B7-H6 dependent reporter cell line is activated by US18 and US20, as well as US12-21 deletions and this activation can be blocked by B7-H6 antibodies or siRNA. However, given the concerns above, it is quite possible that neither US18 or US20 directly impact B7-H6. This would be easy to test using the rAd-US18 and rAd-US20 previously described by the same group (Fielding 2014). Therefore, I suggest that an experiment is included that examines whether US18 and US20 affect B7-H6 expression directly upon ectopic expression.</p><p>For each experiment, the MHC-I downregulation results should be provided as supplemental data to demonstrate that a similar percentage of cells are infected when different mutants are compared.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.22206.023</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><p><italic>Essential revisions:</italic> </p><p><italic>While the comments of the reviewers are attached and should be addressed, the reviewers request that the authors specifically address the following major points in a revision.</italic> </p><p><italic>1) The regulation of B7-H6 by ectopic expression of US18 and/or US20. See reviewers #1 and #3.</italic> </p><p>We have now included data showing targeting of exogenously expressed B7-H6 by US18 and US20, ectopically expressed via adenovirus vectors (panel D in <xref ref-type="fig" rid="fig11">Figure 11</xref>) – see response to reviewer #1, point 3 and reviewer #3, point 3).</p><p><italic>2) Explicit demonstration that US20 effect on MIC-A is impacted by US21. This is mentioned as data not shown but the reviewers would like the authors to show the data. See reviewer #3.</italic> </p><p>In cells infected with the US21 deletion mutant, we observed increased expression of US20 by proteomics. We have included an additional figure (newly added <xref ref-type="fig" rid="fig7">Figure 7</xref>) showing these results (see detailed response to reviewer #3). Reviewer #3 did not directly mention subsequent effects of US20 upregulation on MICA, but any effect cannot be directly analysed in HCMV-infected cells, as infection with the HCMV control virus leads to complete down- regulation of MICA (The MICA signal is effectively zero in HCMV-infected cells).</p><p><italic>3) The% infected cells should be included in each of the figure legends. See reviewer #3.</italic> </p><p>We have inserted% infected cells into the figure legends for <xref ref-type="fig" rid="fig1">Figures 1, 10</xref> (previous <xref ref-type="fig" rid="fig9">Figure 9</xref>) and 12F (see detailed response to reviewer #3).</p><p><italic>4) The statistical analysis of the experiments. See reviewer #2.</italic> </p><p>An unpaired one-way ANOVA analysis of the data shown in <xref ref-type="fig" rid="fig1">Figure 1</xref> has been performed and incorporated into the manuscript (see detailed response to reviewer #2). We have added p values into current <xref ref-type="fig" rid="fig4">Figures 4</xref>, <xref ref-type="fig" rid="fig5">5</xref>, <xref ref-type="fig" rid="fig7">7</xref> (new figure), 8 (previous <xref ref-type="fig" rid="fig7">Figure 7</xref>) and 9 (previous <xref ref-type="fig" rid="fig8">Figure 8</xref>), estimated using Benjamini-Hochberg corrected Significance B values (Cox &amp; Mann, 2008).</p><p><italic>Reviewer #1:</italic> </p><p><italic>It would be informative to express US18 and US20 individually or together by transfection and determine their effects on B7-H6 expression. This will help to confirm that the data with the individual ko viruses are not due to some other effect on the viral genome, such as an inadvertent deletion of an unrecognized ORF in the ko viruses.</italic> </p><p>We carried out whole genome sequencing of the virus genomes from all the US12 deletion mutants. The sequencing data has been submitted to Genbank and Accession numbers are shown in <xref ref-type="table" rid="tbl1">Table 1</xref>. This was stated in the text as follows: ‘Viruses were generated by DNA transfection and the complete genomic sequence of the virus stocks was validated by deep sequencing (<xref ref-type="table" rid="tbl1">Table 1</xref>).’ There were no changes found in the genome of the US18 and US20 deletion mutants, except for the targeted gene deletions.</p><p>The viral transcriptome of the HCMV Merlin strain has been analyzed by a number of groups (Gatherer et al., PNAS 108:19755 2011; Stern-Ginossar et al., Science338:1088 2013).</p><p>Ribosomal profiling identified a number of novel ORFs (Stern-Ginossar et al., 2013). Deletion of the US20 ORF is not predicted to affect any other identified ORFs and deletion of the US18 ORF would be predicted to delete only one single novel ORF (ORFS346CiORF1). This utilises an alternative ATG in the same reading frame as US18 encoding a protein corresponding to the C-terminal 37 amino acids of US18. We know of no evidence for other novel ORFs encoding proteins that might be affected by deletion of US20 or US18.</p><p>We have also performed experiments expressing US18 and US20 individually and together using adenovirus expression vectors, which indicate these proteins are capable of down- regulating B7-H6 levels when expressed on their own outside of the context of HCMV (see response to reviewer #1 point 3 and reviewer #3 point 3).</p><p><italic><xref ref-type="fig" rid="fig11">Figure 11</xref> shows upregulation of B7-H6 expression by control adenovirus infection, helping to make the case that viral infection induces B7-H6 expression. I don't believe this has been shown before, though there are some data indicating that B7-H6 is inducible (Blood 2013, 122:394). However, neither of these points was mentioned in the text which instead focused on the markedly higher levels of B7-H6 expression when the adenoviral vector contained B7-H6.</italic> </p><p>The histogram shown in <xref ref-type="fig" rid="fig11">Figure 11</xref> does not show mock-infected cells, but compares staining levels of the control adenovirus vector with the B7-H6-expressing adenovirus vector using a control murine IgG and B7-H6 specific antibody. We have not investigated the specific regulation of B7-H6 by control adenovirus vector infection. We have altered a line in the Results section to ‘B7-H6 is therefore induced as a ‘stress ligand’ (subsection “B7-H6 is an NK cell activating ligand targeted by US18 and US20”, first paragraph) and added a comment regarding the induction of B7-H6 to the Discussion, ‘…Previously, its expression was shown to be induced by inflammatory stimuli, for example pro-inflammatory cytokines and bacterial-derived toll-like receptor (TLR) ligands (Matta et al., 2013). We show here that B7-H6 expression is induced as a stress protein by HCMV infection (and potentially other virus infections)…’.</p><p><italic>It would be informative if the adenoviral vector contained US18, US20, or both to determine if B7-H6 expression is down-regulated only when both ORFs are ectopically expressed.</italic> </p><p><italic>Finally, it would be of interest to determine if cells constitutively expressing high levels of B7-H6 are affected by US18/US20. If not, the ORFs may be affecting the mechanisms leading to viral induction of B7-H6, rather than B7-H6 itself.</italic> </p><p>We have now provided data showing a reduction in ectopically expressed B7-H6 levels by the US18 or US20 adenovirus vectors individually. The following sentence has been added to the Results section, ‘Ectopic expression of US20, and to a lesser extent US18, from adenovirus vectors reduced levels of exogenously expressed B7-H6 detected by immunoblotting (<xref ref-type="fig" rid="fig11">Figure 11D</xref>).’</p><p>We have also modified a section in the Discussion that now reads ‘…US18 and US20 act together to suppress cell surface expression of B7-H6 in the context of HCMV, thereby inhibiting NK cell activation. US18 and US20 were also able to regulate exogenously expressed B7-H6 when expressed individually. Therefore, they appear to target B7-H6 directly and not cellular pathways leading to the expression of B7-H6.’</p><p>In addition, the US18 and US20 adenoviruses were referenced in the Viruses heading of the Materials and methods section.</p><p><italic>Reviewer #2:</italic> </p><p><italic>Strengths of the study include its innovative approach, in depth analysis of US12 related genes and their broad effect on host immune responses/proteomes, and follow up analyses of specific protein effects (e.g. B7H6). The work is technically excellent, with results effectively presented. The color scheme used to present data for comparison of various HCMV strains, and their effect on many different host molecules has transformed what would appear to be very complex data sets, into ones that are both manageable and elegant. Having implicated specific US12-targeted effects on host proteins, and that these molecules have evolved tag-team strategies to thwart NK cells, is highly interesting. Overall, the findings and conclusions are openly presented, and very compelling. They should generate considerable interest. Although effective strategies and cutoffs were implemented to focus on findings of high significance, there is some question and lingering concern about the use of statistical tests applied, or not, in some experiments.</italic> </p><p><italic>Main concern:</italic></p><p><italic>Multiple comparisons performed in <xref ref-type="fig" rid="fig1">Figure 1B</xref> using a student's t test may be inappropriate. Also, it appears that statistical analyses were not performed in <xref ref-type="fig" rid="fig4">Figures 4</xref>, <xref ref-type="fig" rid="fig5">5</xref>, <xref ref-type="fig" rid="fig7">7C</xref> and 8. Why?</italic> </p><p><xref ref-type="fig" rid="fig1">Figure 1B</xref>: We have now performed unpaired one-way ANOVA analysis with Dunnett’s test for multiple comparisons against the HCMV control. The new analysis did alter the statistical significance of some of the changes in NK degranulation observed. We have incorporated results of the statistical analysis into the figure legend of <xref ref-type="fig" rid="fig1">Figure 1</xref> and the text as follows. ‘Significantly increased levels of NK activation were detected in assays using deletion mutants of 5 different US12 family members: US12 (3 of 4 donors), US14 (1 of 4 donors, with a trend towards increased NK activation in the other 3 donors), US18 (3 of 4 donors), US20 (4 of 4 donors), US21 (4 of 4 donors) (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), while three US12 family deletion mutants (US15, US16, US19) reduced the level of NK cell activation in some donors (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).’</p><p>Estimated p values based on Benjamini-Hochberg corrected Significance B values (Cox &amp; Mann, 2008) have been added to current <xref ref-type="fig" rid="fig4">Figure 4</xref>, current <xref ref-type="fig" rid="fig5">Figure 5</xref>, newly added <xref ref-type="fig" rid="fig7">Figure 7</xref>, current <xref ref-type="fig" rid="fig8">Figure 8C</xref> (previous <xref ref-type="fig" rid="fig7">Figure 7C</xref>) and current <xref ref-type="fig" rid="fig9">Figure 9</xref> (previous <xref ref-type="fig" rid="fig8">Figure 8</xref>). Figure legends have updated accordingly.</p><p><italic>Reviewer #3:</italic> </p><p><italic>Interestingly, and somewhat of concern, deletion of US21 impacted the expression of many other viral genes, including US20 whereas this was not observed when the entire region US12-21 was deleted. The authors argue that this is likely due to the fact that the impact on US20 by US21 no longer occurs when both are deleted, but this is not explicitly shown. I suggest these data are included upon revision.</italic> </p><p>We have inserted the data showing up-regulation of US20 and down-regulation of representative late proteins (UL32 and UL99) in the delta US21 mutant infected cells into a new figure, current <xref ref-type="fig" rid="fig7">Figure 7</xref>. The text present in the manuscript, which previously referred to these data as ‘data not shown’ now references <xref ref-type="fig" rid="fig7">Figure 7</xref> (subsection “Functional independence and co-operation exerted by family members”, second paragraphs).</p><p><italic>Interestingly, they find that deletion of US12, US13 and US20 upregulates UL16 as well deletion of US12-21. Since UL16 prevents the intracellular transport of multiple NKG2D-ligands this result could imply that some of the observed changes in NK cell molecules could be an indirect consequence of US12 family members promoting the expression or stabilization of UL16 which in turn could decrease the lysosomal turnover of target proteins by retaining them in the ER. The possibility that the effects seen are indirect consequences of US12 proteins regulating other viral proteins should be acknowledged more explicitly in the text and it should be clearly stated that this is one of the caveats of the current study.</italic> </p><p>We agree with the reviewer that the effects of US12, US13 and US20 on UL16 could imply the effect of the US12 family on NK ligands may be partly indirect, and that the US12 family could be working in co-operation with other HCMV-encoded immune evasins such as UL16. We do not agree that the US12 family members promote expression/stabilize UL16, since the levels of UL16 actually increase (rather than decrease) during infection with the specific US12 deletion mutants (current <xref ref-type="fig" rid="fig9">Figure 9</xref>). These data support a role for the US12 family in promoting lysosomal degradation of UL16. We recently reported a similar co-operation between US2 and UL141 (Hsu et al., 2015 PLoS Pathogens11(<xref ref-type="bibr" rid="bib4">4</xref>):e1004811) where UL141 retains CD155 in the ER and selectively feeds CD112 to US2 for proteasomal degradation.</p><p>The alterations in levels of UL16 imply that several members of the US12 family are targeting UL16 for lysosomal degradation, together with any UL16-bound ligands. These data also support the idea that the US12 family works through co-operation not only with each other, but potentially with other HCMV proteins. We have inserted the following text into the Discussion, ‘They also imply that some of the effects of the US12 family could be the result of co-operation with other HCMV genes. There is some precedent for this situation as co-operation between US2 and UL141 was observed in the proteasomal degradation of some protein targets e.g. CD112 (Hsu et al., 2015).’</p><p><italic>The authors next focus on one protein in particular, B7-H6, a ligand for the NK cell activating receptor NKp30 that is also found on γδT cells. Using adenoviral expression they demonstrate that B7-H6 activates NK cells. Furthermore, a B7-H6 dependent reporter cell line is activated by US18 and US20, as well as US12-21 deletions and this activation can be blocked by B7-H6 antibodies or siRNA. However, given the concerns above, it is quite possible that neither US18 or US20 directly impact B7-H6. This would be easy to test using the rAd-US18 and rAd-US20 previously described by the same group (Fielding 2014). Therefore, I suggest that an experiment is included that examines whether US18 and US20 affect B7-H6 expression directly upon ectopic expression.</italic> </p><p>As discussed above in the response to reviewer #1 point 3, we now provide data showing a reduction in ectopically expressed B7-H6 levels by the US18 or US20 adenovirus vectors individually. The following sentence has been added to the Results section, ‘Ectopic expression of US20, and to a lesser extent US18, from adenovirus vectors reduced levels of exogenously expressed B7-H6 detected by immunoblotting (<xref ref-type="fig" rid="fig11">Figure 11D</xref>).’</p><p>We have also modified a section in the Discussion that now reads ‘…US18 and US20 act together to suppress cell surface expression of B7-H6 in the context of HCMV, thereby inhibiting NK cell activation. US18 and US20 were also able to regulate exogenously expressed B7-H6 when expressed individually. Therefore, they appear to target B7-H6 directly and not cellular pathways leading to the expression of B7-H6.’ In addition, the US18 and US20 adenoviruses were referenced in the Viruses heading of the Materials and methods section.</p><p><italic>For each experiment, the MHC-I downregulation results should be provided as supplemental data to demonstrate that a similar percentage of cells are infected when different mutants are compared.</italic> </p><p>We have inserted information regarding MHC-I downregulation from experiments comparing different mutants into the figure legends for <xref ref-type="fig" rid="fig1">Figures 1, 10</xref> (previous <xref ref-type="fig" rid="fig9">Figure 9</xref>) and 12F. For reporter assay experiments, cells were infected in the 96-well plates used for the assay and infections were monitored by light microscopy for HCMV cytopathic effect prior to the assay.</p></body></sub-article></article>